Clemson University

TigerPrints
All Dissertations

Dissertations

5-2007

FUNCTIONALIZED NANOMATERIALS:
SYNTHESIS, CHARACTERIZATION, AND
APPLICATIONS
Liangwei Qu
Clemson University, qliangw@clemson.edu

Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations
Part of the Organic Chemistry Commons
Recommended Citation
Qu, Liangwei, "FUNCTIONALIZED NANOMATERIALS: SYNTHESIS, CHARACTERIZATION, AND APPLICATIONS"
(2007). All Dissertations. 64.
https://tigerprints.clemson.edu/all_dissertations/64

This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by
an authorized administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.

FUNCTIONALIZED NANOMATERIALS: SYNTHESIS,
CHARACTERIZATION, AND APPLICATIONS

A Dissertation
Presented to
the Graduate School of
Clemson University

In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
Chemistry

by
Liangwei Qu
May 2007

Accepted by:
Dr. Ya-Ping Sun, Committee Chair
Dr. Dev P. Arya
Dr. Igor Luzinov
Dr. Xiuping Jiang

ABSTRACT

Due to their unique electronic, optical, catalytic and mechanical properties,
nanomaterials (nanoparticles and nanotubes) have been attracting much attention
over the past decades. In this dissertation, polymeric nanoparticles bearing
derivatized D-mannose and galactose molecules were prepared via dispersion
polymerization and their interactions with various bacterial cells were studied.
The results show that there are strong adhesin-specific interactions of the
nanoparticles with E. coli cells, resulting in significant nanoparticles-madiated
cell agglutination.
Poly(ethylene

glycol)-coated

magnetic

polymer

nanoparticles

were

synthesized through miniemulsion polymerization by using macromonomer as
both a comonomer and a surfactant. The resulting magnetic polymer nanoparticles
were successfully used for bio-detection and as magnetic resonance imaging
(MRI) contrast agents.
The functionalization of carbon nanomaterials was also studied. Carbon
nanotubes and vapor grown carbon nanofibers (VGCFs) were functionalized and
solubilized with nylon 6 by using the grafting-from strategy in a two-step process.
These

nylon-functionalized

carbon

nanomaterials

were

systematically

characterized and used for the fabrication of polymer/carbon composite fibers by
electrospinning method.
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OUTLINE OF DISSERTATION

My graduate research concerns the synthesis, characterization and
applications of functionalized nanomaterials, including polymeric nanoparticles
and carbon nanotubes. Among the various biological processes in which
carbohydrate-protein interactions are involved, the attachment of pathogens such
as Escherichia coli to host cells is of particular therapeutic interest. It is
reasonable to use carbohydrates to block their counterpart proteins to prevent the
adhesion process, and the literature reports that various substrates bearing
multiple carbohydrates have been used for this very purpose. We synthetically
prepared polymeric nanoparticles that are covalently functionalized with
derivatized D-mannose and galactose molecules. Their interactions with bacterial
cells were tested by our collaborator Dr. Tzuen-Rong Tzeng in the Department of
Biological Sciences at Clemson University. The results show that there are strong
adhesin-specific interactions of the nanoparticles with E. coli cells, resulting in
significant nanoparticles-mediated cell agglutinations, which can easily be
visualized in terms of electron microscopy imaging. Therefore, these
carbohydrate-conjugated polymeric nanoparticles may not only provide a unique
platform for the visualization of the cell agglutination, but also potentially serve
as therapeutic agents for the inhibition of pathogenic infections (Chapter 1 and 2).
The synthesis, characterization, and application of poly(ethylene glycol)coated magnetic polymer nanoparticles is the second focus of my graduate

research. There has been strong interest in the preparation of magnetic polymer
nanoparticles for use in such biomedical applications as drug delivery, magnetic
resonance imaging, and cell separation. We prepared poly(ethylene glycol)-coated
magnetic polymer nanoparticles through miniemulsion polymerization by using
macromonomer as both a comonomer and a surfactant. Compared with those
previously reported in the literature, our magnetic polymer nanoparticles have the
following advantages: (1) poly(ethylene glycol) are covalently attached to the
polystyrene core, providing much better stability in various environments; (2)
surfaces covered with PEG have proven to be nonimmunogenic, nonantigenic,
and protein resistants and (3) more functional groups will be available for the biofunctionalization of those nanoparticles. These nanoparticles were also used for
the detection of L. monocytogenes in artificially contaminated milk in Dr. Xiuping
Jiang’s group in the Department of Food Science & Human Nutrition at Clemson
University, showing great advantages over the commercially available
Dynabeads. These magnetic polymer nanoparticles were also used as contrast
agents for magnetic resonance imaging (Chapter 3).
Functionalization of carbon nanomaterials such as carbon nanotubes and
carbon nanofibers and their composites is the third focus of my graduate research.
The carbon nanomaterials especially carbon nanotubes (both single wall SWNTs
and multiwall MWNTs) and vapor grown carbon nanofibers (VGCNFs) have
shown exceptional physical, mechanical, electrical, thermal, and optical
properties. The dispersion of carbon nanotubes and carbon nanofibers into
polymeric materials has received much attention for both fundamental and

xxvi

practical interests in polymeric/carbon nanocomposites. The solubilization of
carbon nanotubes has been identified as an effective means of dispersing the
nanotubes homogeneously in wet processing. We functionalized carbon
nanotubes and VGCNFs with nylon 6 by using the grafting-from strategy in a
two-step process, where the covalent attachment of ε-caprolactam molecules to
nanotubes/nanofibers was followed by the anionic ring-opening polymerization of
these bound ε-caprolactam species with the same monomers in bulk. The nylonfunctionalized carbon nanomaterials were systematically characterized and used
for the fabrication of polymer/carbon composite fibers by electrospinning method
(Chapter 4 and 5).

xxvii

xxviii

CHAPTER 1
CARBOHYDRATE-CONJUGATED NANOPARTICLES

1.1 Introduction
Over the last two decades, there has been strong interest in research aimed at
fabricating hybrid nanomaterials from nanoparticles (exhibiting unique electronic,
photonic, and catalytic properties) and biomolecules (displaying unique
recognition, catalytic and inhibition properties).1,2 Nanoparticles including metal,
semiconductor, and polymeric ones, have similar dimensions to those of
biomolecules, such as proteins (enzyme, antigens, antibodies) and DNAs (Figure
1.1).1 The conjugation of nanoparticles with biomolecules yields novel hybrid
biomaterials that can be used as interesting tools for mimicking biofunctional
systems, studying the mechanism of biological processes, as well as developing
chemical means to handle and manipulate biological components.2
Recently, proteins and DNAs have been widely studied in the conjugation
with nanoparticles. These resulting nanomaterials have been used for the
engineering of advanced technical devices and in the industrial production of
active substances for pharmaceutical and biomedical applications.1 The literature
cites many such examples; Nie et al. reported mercaptoacetic acid-stabilized ZnSprotected CdSe QDs, which were coupled with transferrin, a protein that induces
receptor-mediated endocytosis.3 Confocal microscopy revealed that the

Figure 1.1 A gap currently exists in the engineering of small-scale
devices. As a result of their own dimensions, two different types of
compounds appear to be suited for addressing that gap: 1)
biomolecular components, such as proteins, and nucleic acids, and 2)
colloidal nanoparticles. (From Ref. [1].)

2

nanoparticle-protein conjugates were transported into the Hela cells upon
incubations. In another example, Mirkin and co-workers4 as well as other groups59

reported the DNA-directed immobilization of gold nanoparticles that

subsequently formed supramolecular architecture on surfaces. The specific
nucleic acid mediated immobilization of gold nanoparticles were utilized for the
topographic labeling of surface-bound DNA targets, which allowed the highly
sensitive scanometric detection of nucleic acids in DNA chip analyses.10 Several
reviews on nanomaterials conjugated with proteins and DNA have also been
published in the literature.1,2,11,12,13
Carbohydrates are one of four major classes of macromolecules in biology
(together with DNAs, proteins, and lipids) that play important roles in biological
processes. For example, it is known that carbohydrate conjugates on the cell
surfaces are involved in the control of many normal and pathological processes.1419

In order to achieve these relevant biofunctions, carbohydrates usually appear in

the form of clusters or in a multivalent fashion on either cell or tissue surfaces.21
However, reports on carbohydrate-conjugated nanoparticles in the literature are
rather scarce when compared to those on DNA- and protein-based conjugates,20
probably due to the weak interactions between carbohydrates and the
complementary biomolecules (Kd on the order of 10-3 M for 1:1 complexes).
Nevertheless, the synthesis of carbohydrate-conjugated nanoparticles and their
applications in glycoscience, biomedicine and material science will be briefly
discussed in this chapter.

3

1.2 Synthesis of carbohydrate-conjugated nanoparticles
Many kinds of nanoparticles that exhibit carbohydrate conjugation have been
reported in the literature. The core material of the nanoparticles can be gold,
silver, cadmium sulfide, zinc sulfide, iron oxide, and organic polymers, and the
synthesis of each type of carbohydrate-conjugated nanoparticles is discussed in
detail below.

Carbohydrate-conjugated gold nanoparticles. Gold nanoparticles have
unique optical and chemical properties that make them suitable for a number of
applications in bionanotechnology, including optical probes, targeted drug
delivery, and programmed material synthesis.22 Brust and Schiffrin reported an
easy and reproducible synthesis of gold nanoparticles for the first time in 1994.23
The synthesis involved the phase transfer of an anionic AuIII complex from
aqueous to organic solution in a two-phase liquid/liquid system, followed by the
reduction with NaBH4 in the presence of thiol stabilizing ligands. This synthesis
route has been extensively studied and widely used in the preparation of gold
nanoparticles functionalized with proteins and DNA.1 Also based on this method,
Penades et al.24 reported the first synthesis of carbohydrate-conjugated gold
nanoparticles,

which

was

accomplished

by

adding

thiol-derivalized

neoglyconjugate to an aqueous solution of tetrachloroauric acid (HAuCl4) and a
subsequent reduction with NaBH4 (Figure 1.2). Similarly, a series of
carbohydrate-conjugated gold nanoparticles were prepared with the trisaccharide
Lex (Galβ1-4[Fucα1-2]GlcNAcβ1),24 monosaccharide glucose, the disaccharides

4

lactose (Galβ1-4Glcβ1) and maltose (Glcα1-4Glcβ1),25 and the tetrasaccharide
Ley ([Fucα1-2]Galβ1-4[fucα1-2]GlcNAcβ1).26 These nanoparticles are stable and
soluble in water, allowing their convenient manipulation as biocompatible
macromolecules.
Several other groups also used the Brust’s method to prepare various
carbohydrate-conjugated gold nanoparticles. For example, Kataoka et al.27
obtained lactose-conjugated gold nanoparticles with an average core diameter of
8.9 nm by reduction of the metal salt with NaBH4 in the presence of acetal-PEGSH. The PEG acetal terminal groups were converted to aldehydes via gentle acid
treatment, followed by the reaction with p-aminophenyl-b-D-lactopyranoside in
the presence of (CH3)2NHBH3. Terminal lactose content can be regulated by
varying the molar ratio of p-aminophenyl-lactose with p-aminophenyl-mannose in
reaction mixtures, respectively (Figure 1.3). Gervay-Hague et al.28 prepared
glucose- and galactose-conjugated gold nanoparticles and Lin et al.29 synthesized
gold nanoparticles conjugated with mannose, glucose and galactose. Kamerling et
al.30 reported a series of water-soluble gold nanoparticles conjugated with
glycosides

β-D-GlcpNAc3S-(1-3)-α-L-Fucp-(1-O)(CH2)3S(CH2)6SH,

GlcpNAc3S-(1-3)-β-L-Fucp-(1-O)(CH2)3S(CH2)6SH,

β-D-

β-D-GlcpNAc3S-(1-

O)(CH2)3S-(CH2)6SH, α-L-Fucp-(1-O)(CH2)3S(CH2)6SH, β-D-Glcp-NAc3S-(1-3)α-L-Galp-(1-O)(CH2)3S(CH2)6SH,

β-D-Glcp-NAc-(1-3)-α-L-Fucp-(1-

O)(CH2)3S(CH2)6SH, and β-D-Glcp3S-(1-3)-α-L-Fucp-(1-O)(CH2)3S(CH2)6SH.
Barchi et al.31 described the synthesis of gold nanoshells encapsulated with up to
90 units of the Thomsen-Friedenreich (TF) tumor-associated carbohydrate antigen

5

disaccharide (Galβ1-3GalNAc-α-O-Ser/Thr). The assembly of a suitably linked
designer glycopeptides as a precursor to similar multivalent presentations on gold
was also reported.

Carbohydrate-conjugated silver nanoparticles. Silver nanoparticles have
been shown to cause surface-enhanced fluorescence, which was attributed to an
enhanced field near the silver surface. Russell et al.32 prepared the mannoseconjugated silver nanoparticles, first through the reduction of a silver salt with
NaBH4, next followed by the addition of 2-mercaptoethyl α-D-mannopyranoside.
Lakowicz

et

al.33

synthesized

dextran-

and

glucose-conjugated

silver

nanoparticles in a modified Brust reaction with a 1:1 molar ratio of tiopronin and
silver nitrate in methanol. Tiopronin ligands coated on silver nanoparticles were
displaced by thiolate boronic acid through ligand exchange, which were then
coupled with dextran and glucose (Figure 1.4)

Carbohydrate-conjugated quantum dots. One of the fastest moving and
most exciting endeavors in current nanotechnology research is the use of highly
luminescent inorganic nanoparticles, or quantum dots (QDs), as fluorescence
probes in biology.3,34,35,36 Popular core materials for QDs include CdS, CdSe, etc.
Compared to conventional fluorescent dyes, QDs have four distinct advantages:
(1) QDs fluorescence absorption and emission are conveniently tunable by their
sizes and material compositions, and the emission peaks are of narrow spectral
linewidths; (2) QDs have high quantum yields that often range from 35-50% for

6

Figure 1.2 Preparation of the disaccharide lactose- and the
trisaccharide Lewisx-conjugated gold nanoparticles. (From Ref.
[24].)

7

Figure 1.3 Preparation of functionalized gold nanoparticles covered with
heterobifunctional PEG. (From Ref. [27].)

8

Figure 1.4 Preparation of tiopronin-monolayer-protected silver
nanoparticle, ligand exchange, and coupling with saccharide. (From Ref.
[33].)
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core (CdSe)-shell (ZnS) nanoparticles; (3) QDs are approximately 100 times as
stable against photobleaching as organic dyes; and (4) QDs often have a long
fluorescence lifetimes of several hundred nanoseconds. There are two synthetic
procedures that are used to produce QDs with the desired optical properties for
biomedical research and applications. The first is an organometallic synthetic
procedure developed by Murray et al.37 The second is known as the “Greener”
method, which uses environmentally more benign metallic salts and organic
stabilizing agents.38,39,40 Recently, peptides and proteins, antibodies, DNAs and
other small ligands were successfully conjugated to the surface of QDs through
the “Greener” method. QD–streptavidin conjugates, for example, have been used
to stain tissues, cells, and intracellular organelles.34 Likewise, QD–avidin–
antibody

conjugates

improved

the

sensitivity

of

conventional

fluoroimmunoassays.3 However, there are few reported examples on the synthesis
of carbohydrate-conjugated QDs. The first carbohydrate-conjugated QDs was
reported by Rosenzweig et al,41 who successfully incorporated negatively charged
luminescent CdSe-ZnS QDs into novel luminescent glyconanospheres averaging
190 nm in diameter through electrostatic interactions with carboxymethyldextran
and polylysine. The resulting dextran-conjugated QDs showed high affinity
toward the glucose binding protein-Concanavalin A (Con A). Sun et al.42 reported
the site-specific multivalent carbohydrate labeling of QD surface using a biotin
chain-end-functionalized glycopolymer, thusly demonstrating the potential value
of these multivalent carbohydrate polymers in both imaging and biocapture
applications. Penades et al.43 prepared, for the first time, water soluble CdS
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nanoclusters functionalized with biologically significant oligosaccharides by
means

of

a

straightforward

one-step

procedure

(Figure

1.5).

These

oligosaccharides-conjugated QDs displayed the carbohydrate antigens in a threedimensional and polyvalent array, mimicking glycosphingolipid presentation on
the cell surface and providing a convenient tool for studying and interfering
carbohydrate-mediated cell-cell adhesion process. Fang et al.44 reported the
encapsulation of QDs with biologically important β-N-acetylglucosamine, which
specifically bound to wheat germ agglutinin, caused subsequent fluorescence
quenching and aggregation. Liu et al.45 synthesized β-cyclodextrin (β-CD)modified CdSe (β-CD/CdSe) and CdSe-CdS core-shell structured (β-CD/CdSeCdS) QDs by a single-phase approach in aqueous solutions. These highly
quantum efficient, water soluble receptor-modified QDs may serve as active
component in the construction of QD-based hybrid nanomaterials for practical
applications, such as in clinical diagnosis and solar energy conversion.

Carbohydrate-conjugated polymeric nanoparticles. Many researchers have
conjugated carbohydrates onto water-soluble synthetic linear polymers.46,47
However, research on the conjugation of sugars onto polymeric nanoparticles is
much less common.
Maruyama et al.48 described a novel method of preparing polymeric
nanoparticles bearing high density carbohydrate chains on their surfaces.
Carbohydrate-bearing nanoparticles of poly(lactic acid) or polystyrene were
prepared by the solvent evaporation method using a carbohydrate-carrying
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Figure 1.5 Preparation of glyco-QDs. Reagents and conditions: (a) Cd(NO3)2·4H2O,
Na2S, pH 10, H2O. (From Ref. [43].)
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polystyrene derivative which served as both an emulsifier and the surface
coating. The obtained particles were specifically aggregated by a carbohydratespecific lectin, showing that the polystyrene derivative was retained on the
particle surfaces with expressed carbohydrate residues.
Cho et al.49 reported the preparation of nanoparticles bearing carbohydrate
chains on the surface by the simple one-step diafiltration method. The resulting
nanoparticles, which did not aggregate, were of high yield, small size, and narrow
size distribution. The high-density carbohydrate chains on the particles could also
be readily recognized by cells.
Akashi et al. developed a method for the preparation of “core-corona
nanospheres”, namely nanoparticles with a hydrophobic polymer core and
hydrophilic polymer corona containing functional groups.50,51 Through an amide
linkage between a lactose-lactose and the primary amine group, they successfully
conjugated lactose onto nanoparticles with a polystyrene core and a
poly(vinylamine) corona, and analyzed the binding of the resultant carbohydrateconjugated nanoparticles with lactose-specific Ricinus communis agglutinin
(RCA120) (Figure 1.6).52,53 they also synthesized a glucose-containing
macromonomer, and copolymerized it with a styrene in order to prepare
polystyrene core-glucose corona nanoparticles.54
Similarly, Sun et al.55 synthesized mannosylated polystyrene nanoparticles via
dispersion polymerization. The mannosylated polymeric nanoparticles were
effective in the agglutination of E. coli ORN178 via adhesion-specific
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interactions, and the nanoparticles-mediated bacteria cell agglutination was
conveniently visualized by using typical electron microscopy methods.
Recently, mixed micelle methodologies were employed to construct
nanoparticle scaffolds with a hydrophobic core, a hydrophilic cross-linked shell,
and several different stoichiometries of surface-displayed mannoside groups.56
Specifically, the conjugation of mannose onto the hydrophilic chain terminus of
the amphiphilic diblock copolymer precursor was achieved by the growth of the
diblock copolymer from a mannoside-functionalized initiator under typical Atom
Transfer Radical Polymerization (ATRP). Mixed micelle formation between the
amphiphilic diblock copolymer and mannosylated amphiphilic diblock copolymer
was then undertaken, followed by condensation-based cross-linking between the
acrylic acid residues present in the periphery of the polymer micelles to afford
SCK nanoparticles (Figure 1.7). The content of the mannose functionalities was
able to be adjusted by controlling the stoichiometric ratios of mannosylated and
nonmannosylated diblock polymers.

1.3 Applications of Carbohydrate-Conjugated Nanoparticles
Due to their size range, surface properties, and other physical properties,
carbohydate-conjugated nanopaticles are ideal bio-mimetic model systems for use
on cell surfaces with displayed sugars, and are thus widely used in the studies of
carbohydrate-protein interactions and carbohydrate-carbonhydrate interactions.
Other applications of these nanoparticles include biolabels and biosensors.

14

Figure 1.6 Schematic representation of a lactose-immobilized
nanosphere and subsequent hepatocyte binding. (From Ref. [53].)
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Figure 1.7 Construction of mannosylated SCK nanoparticles, with
control over the number of mannose residues being provided by the
formation of mixed micelles. (From Ref. [56].)
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Carbohydrate-conjugated

nanoparticles

in

carbohydrate-protein

interactions. While carbohydrate-protein interactions are of fundamental
importance for a large number of physiological events, monovalent carbohydrateprotein interactions are typically associated with weak binding constants, which,
by nature, can be compensated by the presentation of multiple ligands to
individual receptors. The polyvalent interactions between multiple ligands and
their receptors can, collectively, be much stronger than corresponding monovalent
interactions. In order to better understand these interactions, linear polymers, and
other two- and three-dimensional species bearing multiple mannose molecules
have been developed and used to facilitate the required multivalent binding.56-62
Several groups have used carbohydrate-conjugated nanoparticles to study the
carbohydrate-protein interactions. Among the earliest reports, Kataoka et al.
observed

that

lactose-conjugated

gold

nanoparticles

exhibited

selective

aggregation when exposed to Recinus communis agglutinin (RCA120), a bivalent
lectin. RCA120 specifically recognizes the β-D-galactose residue, causing
significant changes in the absorption spectrum with a concomitant visible color
change from pinkish-red to purple (Figure 1.8).27 Furthermore, the degree of
aggregation was proportional to lectin concentration and lactose density on the
surface of the particles, permitting the system to be utilized for quantitative
assay.27
The surface plasma resonance (SPR) technique can be applied to
quantitatively analyze the carbohydrate-protein interactions together with
carbohydrate-conjugated nanoparticles. Lin et al.29 determined that the binding
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Figure1.8 Schematic representation of the reversible aggregation
dispersion behavior of Lactose-PEGylated gold nanoparticles by
sequential addition of RCA120 lectin and galactose with actual
concommitant change in color from pinkish-red to purple to pinkishred. (From Ref. [27].)

18

between mannose-conjugated nanoparticles and Con A exhibited a strong
multivalent effect, while also determining that the affinity could be adjusted by
altering the nanoparticles size or sugar moiety.
Russell et al.63 reported a rapid, quantitative colorimetric detection of
carbohydrate binding proteins using mannose-stabilized gold nanoparticles. The
sizes of the mannose-stabilized gold nanoparticles provide specific optical
properties for the colorimetric determination of sub-µM concentrations of the
lectin Con A. By measuring the intensity change of the surface plasmon
absorption band at 620 nm, the selective aggregation process can be used to
provide quantitative and rapid data acquisition.

Carbohydrate-conjugated nanoparticles in carbohydrate-carbohydrate
interactions. Carbohydrates, the most prominently exposed structures on the
surface of living cells, are integral components in cell-cell adhesion and
communication. Since Hakomori’s initial report in 1989, detailing how
glycosphingolipid self-interactions occur by way of the Lewisx determinant
(Galβ1-4[Fucα1-3]

GlcNAcβ1-3Galβ1-4Glcβ)

(Lex),

resulting

in

Lex

carbohydrate-dependent cell adhesion in the compaction of mouse embryos,64
several

other

glycosphingolipids

involved

in

carbohydrate-carbohydrate

interactions have already been identified. These carbohydrate-carbohydrate
interactions include KDNGM3-Gg3 interaction in the binding of sperm to egg
membranes in rainbow trout fertilization65 and the GM3-Gg3 interaction between
lymphoma and melanoma cells. 66
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Various model systems have been proposed to investigate these carbohydratecarbohydrate interactions. Because such interactions are weak by nature, several
groups used clustered oligosaccharides as model systems for these investigations.
Penades et al.24 devised Lex-coated gold nanoparticles to investigate the selective
self-recognition

of

the

Lex

antigen

through

carbohydrate-carbohydrate

interactions. The aggregation of the Lex-coated nanoparticles in the presence of
Ca2+ via the homotropic Lex-Lex interactions were verified by transmission
electron microscopy (TEM) (Figure 1.9). In the same report, the first quantitative
kinetic data for Lex self-recognition and direct evidence of its Ca2+ dependency
were also provided. Furthermore, isothermal titration calorimetry was used to
show that the Ca2+-mediated aggregation is a slow process that occurs with a
decrease in enthalpy of 160 ± 30 kcal/mol, while the heat evolved in the case of
lactose and maltose glyconanoparticles is very low and thermal equilibrium was
quickly achieved in the experiment.67,68
Similarly, water-soluble gold glyconanoparticles coated with synthetic
carbohydrates related to the sulfated disaccharide fragment were used as
multivalent systems to investigate the g-200 glycan-glycan interactions by TEM.69
Very recently, Russell et al.70 reported that the self-assembled deposition of
lactose derivatives on gold nanoparticles provides multivalent carbohydrate
surfaces that can be used to mimic the measurement of biologically relevant
carbohydrate-carbohydrate interactions. They determined that the aggregation of
lactose nanoparticles were quantitatively dependent on calcium ion concentration,
while the analytical sensitivity and working dynamic range of the calcium-
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induced aggregation were dependent upon the length of the ethylene glycol chain
(Figure 1.10).

Carbohydrate-conjugated

nanoparticles

as

biolabels.

Although

nanoparticles functionalized with proteins, peptides, and nucleic acids have been
extensively used as biolabels in biology,1 only a handful of reports in the literature
have reported the use of carbohydrate-conjugated nanoparticles to explore the
analogous applications of biolabels.
Lin et al.61 first reported a method of labeling specific proteins on the cell
surfaces using mannose-conjugated gold nanoparticles. These nanoparticles were
tested for their ability to bind to mannose-specific adhesin FimH of type 1 pili in
Escherichia coli. Two E. coli strains - ORN178 (expressing wild-type type 1 pili)
and ORN208 (deficient of the FimH gene and expressing abnormal type 1 pili that
failed to mediate D-mannose-specific binding) - were used in experiments to
confirm the specific binding of the mannose-conjugated nanoparticles to FimH. It
was also determined, through TEM, that the particles bound specifically to FimH
adhesion of bacteria type 1 pili; the interactions were stronger than with free
mannose only, as revealed in the competition assay (Figure 1.11). This discovery
suggested that the strong and selective nanoparticle-adhesin binding might be
used as a novel route for the labeling of specific proteins on the cell surface. A
significant advantage for the use of these carbohydrate-conjugated nanoparticles
is that the target receptors on the cell surface could be detected easily under an
electron microscope.
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Figure 1.9 Transmission electron micrographs and core size-distribution
histograms (insets in a, b) of: a) 3-Au (0.1 mgmL-1 in water); b) 2-Au (0.1
mgmL-1 in water); c) 3-Au (0.1 mgmL-1 in 10 mm CaCl2 solution); d) 3-Au
(0.9 mgmL-1 in 10 mm CaCl2 solution); e) the same as (c). EDTA; f) the
same as (d).EDTA; g) 2-Au (0.1 mgmL-1 in 10 mm CaCl2 solution); h) 2-Au
(0.9 mgmL-1 in 10 mm CaCl2 solution); EDTA = ethylendiaminetetraacetate.
(From Ref. [24].)
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Figure 1.10 Schematic representation of the formation of large
aggregates following calcium-mediated carbohydrate-carbohydrate
interaction of the lactose nanoparticles. (From Ref. [70].)
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Figure 1.11 Typical TEM images of sectioned areas of (A) pili of the
E. coli ORN178 strain bound with m-AuNP, (B) the E. coli ORN208
strain deficient of the fimH gene without m-AuNP binding. The
experiments were performed in LB at room temperature. Scale bar =
100 nm. (From Ref. [61].)
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Sun et al.54 employed a similar approach. In their experiments they used
mannosylated

polymeric

nanoparticles

as

biolabels,

and

synthesized

mannosylated polymeric nanoparticles in the dispersion polymerization of
mannosylated macromonomer with styrene in ethanol-water (4/1, v/v) mixture.
The resulting nanoparticles were quite effective in the agglutination of E. coli
ORN178 via adhesion-specific interactions, with such significant agglutination
easily visualized by TEM (Figure 1.12).
Because of their optical properties, QDs have also been widely used as
fluorescent probes in biology. Fang et al. recently reported the use of β-Nacetylglucosamine (GlcNAc)- and mannose-conjugated QDs to observe the
different distributions of the GlcNAc and mannose receptors on the surfaces of
sperms obtained from mice, pig, and sea-urchins. Confocal microscopy images
showed that GlcNAc-conjugated QDs bound to the head of the sperm, while those
with mannose moieties spread over the whole sperm body.71

Carbohydrate-conjugated nanoparticles in bio-detaction. The aggregation
of noble metal nanoparticles induced by specific bioaffinity reactions has been
exploited as a practical tool for the development of colorimetric detection of DNA
hybridization, immunoassays, and the controlled assembly of nanoparticles.
Geddes et al.72 reported an approach to glucose sensing by using high-molecularweight dextran-conjugated gold nanoparticles, which is based on the aggregation
and disassociation of 20-nm gold particles and the changes in plasmon absorption
induced by the presence of glucose.
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Lin et al.73 demonstrated the feasibility of carbohydrate-functionalized
nanoparticles for the simultaneous enrichment and isolation of target proteins
from a mixture at the femtomole level. The analytical scheme is illustrated in
Figure 1.13. The target proteins were captured by the carbohydrate-conjugated
nanoparticles through the specific carbohydrate-protein interactions and directly
analyzed by MALDI-TOF MS.

Carbohydrate-conjugated nanoparticles in therapeutic applications. With
a grater understanding of the importance of carbohydrate-protein interactions in
microbiological contexts, researchers began to investigate the feasibility of
antiadhesion therapy,74 which is based on the following scientific hypotheses and
research findings: (1) microbial infection is initiated by the adhesion of the
microorganism to the host tissue; (2) adhesion is mediated through the
interactions between microbial surface adhesins and carbohydrate receptors on the
host cell surface; and (3) microbial adhesion can be inhibited by carbhohydrates.
Therefore, it is reasonable to use carbohydrates to block their counterpart proteins
to prevent the adhesion process. Several soluble natural and synthetic
carbohydrates have been used in anti-adhesion treatments against bacteria.
Among the very few papers reporting the use of carbohydrate-conjugated
nanoparticles for this purpose, Penades et al. prepared lactose-conjugated gold
nanoparticles as an antiadhesive tool in tumoral metastasis progression in vivo. It
was

demonstrated

that

specific

tumor-associated

carbohydrate

antigens

(glycosphingolipids and glycoproteins) are involved in the initial step of tumor
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spreading. Using a mouse melanoma model, the authors showed that these
lactose-conjugated nanoparticles can reduce the progression of experimental
metastasis, indicating the potential of this glyconanotechnology for use in other
anti-adhesion therapies (Figure 1.14).75
In summary, this chapter reviewed current best practices regarding the
synthesis and applications of carbohydrate-conjugated nanoparticles. Although
much progress has been made in the synthetic methodologies of carbohydrateconjugate nanoparticles, their applications are still in their infancy.
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a

b

2 µm

2 µm

c

d

500 nm

500 nm

Figure 1.12 Lower magnification (a, b) and higher magnification (c, d)
TEM images (dark field) showing the agglutination of E. coli ORN178
mediated by D-mannose tethered polymeric nanoparticles. (From Ref.
[54].)

28

Figure 1.13 The analytical scheme of the NBAMS technique for the
specific capture of target proteins and the rapid mapping of bindingepitope-containing peptides.
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Figure 1.14 Schematic representation of the experimental design for the
evaluation of the antimetastatic potential of lacto-GNPs. Control group C
(mice inoculated only with lacto-GNPs in Hank's solution) is not
represented. (From Ref. [75].)
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CHAPTER 2
GALACTOSYLATED AND MANNOSYLATED POLYMERIC
NANOPARTICLES: SYNTHESIS, CHARACTERIZATION, AND
APPLICATIONS

2.1 Introduction
It has been established in the literature that carbohydrates serve as recognition
molecules in the adhesion of bacteria to host cells via carbohydrate-protein
interaction.1,2,3 For example, the attachment of enteropathogens such as
Escherichia coli to epithelial cells is mediated by mannose-specific adhesins on
the surface of these organisms, which bind to mannose or mannose-like receptors
on the mucosal cell.4-10 There have been considerable scientific interests in an
understanding and mimicking of the bacterial adhesin-receptor interactions for
various purposes, including pathogen detection and treatment of bacterial
infections.2,11-15 However, carbohydrate-protein interactions are generally weak,
which in nature are enhanced by the presentation of multiple carbohydrate ligands
to individual receptors.16-18 In the study of adhesions with bacterial cells, linear
polymers and other two- and three-dimensional species bearing multiple mannose
molecules have been developed and used to facilitate the required multivalence
binding.16-23
Microspheres or beads have been widely used in biological and medical
assays.24 However, their relatively large sizes are disadvantageous in some

applications, such as in the capturing of bacterial cells in immunoseparations.25
Recently, nanoscale particles have been developed and studied as novel or
improved carriers for bioactive functionalities.26-33 For examples, nanoscale gold
particles coated with tethered mannose molecules were shown to selectively bind
to type 1 pili in E. coli.29 It was suggested that the strong and selective binding
presents a novel method of labelling specific protein on the cell surface using
carbohydrate conjugated nanoparticles and that a significant advantage with the
use of nanoparticles is to allow relatively easy and direct detection of the target
receptors on the cell surface under an electron microscope.29 Similarly, lactoseconjugated gold nanoparticles were found to exhibit selective aggregation when
exposed to Recinus communis agglutinin, accompanied by significant color
changes for optical detection.30 In other related reports, Mumper and coworkers
showed that the macrophage cell uptake and binding of mannan-coated cationic
nanoparticles were indeed mannose receptor-mediated.32 Gu et al. demonstrated
that magnetic FePt nanoparticles with multiple antibiotic units could be used to
detect E. coli at a very low concentration level.33
Polymeric nanoparticles can be prepared conveniently in sizes on the order of
100 nm, which are between those of microspheres and gold nanoparticles.28,31
The particles can be tethered covalently with the desired bioactive groups or
biological species, providing a versatile and robust platform in the design of
specific nanoscale sensors or delivery vehicles for various purposes.
In this work, we synthetically prepared polymeric nanoparticles that are
covalently functionalized with derivatized galactose molecules (Part I) and D-
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mannose molecules (Part II) through dispersion polymerization (Scheme 2.1).
These galactosylated and mannosylated nanoparticles are much larger in size than
those based on the nanoscale gold particles, thus bearing considerably more
surface-tethered mannose moieties. There are strong adhesin-specific interactions
of the nanoparticles with E. coli cells. Since a single nanoparticle is capable of
binding more than one cell, the adhesion interactions result in significant
nanoparticles-mediated cell agglutinations, which can easily be visualized in
terms of electron microscopy imaging.
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2.2 Galactosylated Polymeric Nanoparticles
2.2.1 Experimental Section
Materials. β-D-Galactosepentaacetate, p-chloromethylstyrene (90%), 2chloroethanol, 4-dimethylaminopyridine (DMAP, 99%), hydrochloric acid, Nhydroxysuccinimide (93+%), MES hydrate (99%), pyridine (99%), sodium
hydride (60%, dispersed in mineral oil), sodium bicarbonate (powder), palladium
on activated carbon (10% Pd), and succinic anhydride (99%) were purchased
from Acros, azobis(isobutyronitrile) (AIBN, 98%) was from Aldrich, N,N’dicyclohexylcarbodiimide, triphenylphosphine (99%), sodium azide (99%), and ptoluenesulfonyl chloride (98%) were from Alfa Aesar, styrene was from Baker,
polyethylene glycol (PEG, MW ~ 2000) was from Fluka, tetrabutylammonium
iodide (98%) was from Lancaster, and ethanol, chloroform, methylene chloride,
THF, DMF, and diethyl ether were from Fisher. THF and methylene chloride
were distilled over sodium and calcium hydride, respectively, and DMF was dried
with calcium hydride and distilled under reduced pressure before use. Deuterium
oxide (99.9%) and deuterated chloroform for NMR measurements were supplied
by Cambridge Isotope Laboratories. Cellulose membrane tubing for dialysis was
obtained from Sigma.
Measurements. NMR measurements were performed on a JEOL Eclipse
+500 NMR spectrometer. Dynamic light scattering characterization was carried
out on a Coulter N4 Plus particle sizer. Transmission electron microscopy (TEM)
analyses were conducted on an Hitachi HD-2000 TEM/STEM system equipped
with a CCD camera for digital imaging.
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Synthesis of galactosylated nanoparticles. The galactosylated nanoparticles
were prepared via copolymerization of galactosylated macromonomer with
styrene. Galactosylated macromonomer was synthesized in terms of the
procedures shown in Scheme 2.2, Scheme 2.3, and Scheme 2.4.
ω-Hydroxy-St-PEG macromonomer 1. NaH (~60%, 0.6 g, 15 mmol) was
added to a solution of polyethylene glycol (Mw ~ 2000, 20 g, 10 mmol) in THF
(100 mL). After being kept at 40 °C for 4 h, the reaction mixture was cooled to 34
°C, added with p-chloromethylstyrene (1.83 g, 12 mmol), kept at 30 °C for 24 h,
and then neutralized with diluted HCl. Sodium chloride was removed by
filtration. The resulting solution was concentrated and precipitated into cold ether,
followed by filtration for the solids and drying in a vacuum oven at room
temperature to obtain macromonomer 1 (20.1 g, 95% yield). 1H NMR (500 MHz,
CDCl3): * 7.38 (d, J = 7.30 Hz, 2H), 7.30 (d, J = 6.9 Hz, 2H), 6.72 (m, 1H), 5.74
(d, J = 17.85 Hz, 1H), 5.24, (d, J = 10.55 Hz, 1H), 4.65 (s, 2H), 3.4-4.0 (m, 180H)
ppm;

13

C NMR (125 MHz, CDCl3): * 137.95, 136.99, 136.60, 128.01, 126.26,

113.82, 73.00, 72.60, 70.41, 69.45, 61.78 ppm.
ω-Tosylate-St-PEG macromonomer 2. Macromonomer 1 (10 g, 4.3 mmol)
was dissolved in dry CH2Cl2, followed by the addition of pyridine (5.2 g, 65
mmol). The mixture was cooled to 0 °C, and then p-toluenesulfonyl chloride
(12.65 g, 65 mmol) was added. The resulting mixture was stirred at room
temperature for 12 h. After CH2Cl2 was removed on a rotary evaporator, to the
resulting oil were added CHCl3 (20 mL) and H2O (10 mL). The organic layer was
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washed with HCl (2 M), aqueous NaHCO3 (5%), and then H2O. It was dried
with MgSO4 powder, filtered, and precipitated into cold ether. After washed with
cold ether several times, it was dried in a vacuum oven at room temperature
overnight to obtain macromonomer 2 (9.5 g, 92% yield). 1H NMR (500 MHz,
CDCl3): * 7.78 (d, J = 8.25 Hz, 2H), 7.25-7.44 (m, 6H), 6.69 (m, 1H), 5.72 (d, J
= 17.85 Hz, 1H), 5.22 (d, J = 11.0 Hz, 1H), 4.55 (s, 2H), 4.15 (t, J = 4.80 Hz, 2H),
3.40-3.80 (m, 180 H), 2.44 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3): * 144.83,
137.95, 136.96, 136.59, 133.04, 129.89, 128.03, 127.99, 126.25, 113.81, 72.97,
70.88, 70.78, 70.69, 70.61, 69.44, 69.30, 68.71, 21.71 ppm.
ω-Azide-St-PEG macromonomer 3. Macromonomer 2 (8.9 g, 4.2 mmol)
was dissolved in DMF (60 mL), and to the solution was added NaN3 (2.76 g, 42
mmol) and tetrabutylammonium iodide (0.2 g, 0.54 mmol). After being kept at 40
°C for 4 h, the mixture was precipitated into cold ether to remove DMF. The
resulting solids were re-dissolved in CHCl3, and the solution was dried with
MgSO4. Upon filtration to remove MgSO4, the CHCl3 solution was concentrated
and again precipitated into cold ether, followed by the filtration again and drying
in a vacuum oven at room temperature to obtain macromonomer 3 (8.3 g, 95%
yield). 1H NMR (500 MHz, CDCl3): * 7.38 (d, J = 8.25 Hz, 2H), 7.30 (d, J = 7.35
Hz, 2H), 6.70 (m, 1H), 5.73 (d, J = 16.55 Hz, 1H), 5.23 (d, J = 11.0 Hz, 1H), 4.54
(s, 2H), 3.80-3.54 (m, 180 H), 3.38 (t, J = 5.05 Hz, 2H) ppm;

13

C NMR (125

MHz, CDCl3): * 137.95, 137.00, 136.60, 128.00, 126.26, 113.82, 73.00, 70.70,
70.63, 69.45, 50.70 ppm.
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ω-Amine-St-PEG macromonomer 4. Macromonomer 3 (3 g, 1.38 mmol),
PPh3 (0.44 g, 1.65 mmol), and H2O (37.3 mg, 2.1 mmol) were dissolved in THF
(25 mL), and the mixture was stirred at room temperature for 36 h. The reaction
mixture was concentrated and precipitated into cold ether, followed by filtration
for the solids and drying under vacuum at room temperature to obtain
macromonomer 4 (2.6 g, 94% yield). 1H NMR (500 MHz, CDCl3): * 7.39 (d, J =
8.25 Hz, 2H), 7.30 (d, J = 8.20 Hz, 2H), 6.71 (m, 1H), 5.74 (d, J = 18.30 Hz, 1H),
5.23 (d, J = 11.45 Hz, 1H), 4.56 (s, 2H), 3.8-3.4 (m, 180H), 2.88 (t, J = 5.25 Hz,
2H) ppm;

13

C NMR (125 MHz, CDCl3): * 137.94, 136.97, 136.59, 127.99,

126.25, 113.81, 73.10, 72.98, 70.70, 70.61, 70.33, 69.43, 41.84 ppm.
ω-Carboxyl-St-PEG macromonomer 5.

Macromonomer 4 (1.96 g, 9.2

mmol), succinic anhydride (1.85 g, 18.4 mmol), and DMAP (10 mg, 0.08 mmol)
were dissolved in CH2Cl2 (20 mL), and the solution was stirred at room
temperature for 36 h. Water (5 mL) was added to quench the reaction. The
solution was washed with water (5 mL x 3), and the organic layer was dried with
MgSO4 and filtered. The resulting solution was concentrated and precipitated into
cold ether, followed by filtration for the solids and drying under vacuum at room
temperature to obtain macromonomer 5 (1.63 g, 80% yield). 1H NMR (500 MHz,
CDCl3): * 7.40 (d, J = 8.21 Hz, 2H), 7.34 (d, J = 7.80 Hz, 2H), 6.27 (m, 1H), 5.76
(d, J = 18.35 Hz, 1H), 5.24 (d, J = 10.1 Hz, 1H), 4.58 (s, 2H), 3.90-3.40 (m,
180H), 2.67 (t, J = 6.65 Hz, 2H), 2.56 (t, J = 6.62 Hz, 2H) ppm; 13C NMR (125
MHz, CDCl3): * 174.26, 172.67, 137.92, 136.97, 136.58, 128.00, 126.26, 113.83,
73.00, 72.00-70.3(m), 70.25, 69.65, 69.42, 39.51, 31.03, 30.27 ppm.
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2-Chroloethyl-2,3,4,6-tetra-O-acetyl-galactopyranoside

6. To

a

cold

solution (0 ºC ) of β-D-galactose-pentaacetate (7.8 g, 20 mmol) and 2chloroethanol (1.93g, 24 mmol) in dry CH2Cl2 was added BF3.OEt2 (48% Et2O
solution, 15ml, 120mmol) dropwise. Stirring was continued for 1 h at 0 °C, then
at room temperature (12 h). The mixture was washed with cold water (10 mL *
3), aqueous sodium hydrogencarbonate (5%, 10 mL), cold water (10 mL). The
organic phase was dried over anhydrous MgSO4. After filtration, the solvent was
removed on a rotary evaporator. Purification by column chromatography on silica
gel using ethyl acetate : hexane (1:1) as eluent to afford 6 as a colorless solid
(7.5g , 91%). 1H NMR (500 MHz, CDCl3): δ 5.39 (d, 1H), 5.22 (q, 1H), 5.02 (dd,
1H), 4.53 (d, 1H), 4.20-4.16 (m, 1H), 4.15-4.09 (m, 2H), 3.91 (t, 1H), 3.78-3.73
(m, 1H), 3.64-3.61 (t, 2H), 2.15 (s, 3H), 2.07 (s, 3H), 2.05 (s, 3H), 1.98 (s, 3H);
13C NMR (125 MHz, CDCl3): δ 170.51, 170.32, 170.26, 169.68, 101.75, 70.87,
70.81, 70.05, 68.62, 67.02, 61.34, 42.64, 20.89, 20.79, 20.77, 20.69. MALDI:
433.88 (M+Na) +.
2-Azidoethyl-2,3,4,6-tetra-O-acetyl-galactopyranoside 7. Sodium azide
(5.6g, 80 mmol) was added to a mixture of 6 (7.5g, 18 mmol) and 18-crown-6
(100 mg) in DMF (30ml). The system was kept at 65 ºC for 24 h. Water (60ml)
and toluene (120ml) were added, organic layer was dried and concentrated, then
followed by column chromatography on silica gel with the eluent of ethyl acetate
: hexane (1:1.5) to give 7 (6.5 g, 86% ). 1H NMR (500 MHz, CDCl3): δ 5.37 (dd,
1H), 5.23-5.19 (t, 1H), 5.01-4.99 (dd, 1H), 4.53 (d, 1H), 4.19-4.09 (m, 2H), 4.044.00 (m, 1H), 3.92-3.88 (m, 1H), 3.70-3.64 (m, 1H), 3.51-3.45 (m, 1H), 3.30-3.25

48

(m, 1H), 2.13 (s, 3H), 2.04 (s, 3H), 2.02 (s, 3H), 1.95 (s,3H);

13

C NMR (125

MHz, CDCl3): δ 170.48, 170.32, 170.23, 169.57, 101.21, 70.97, 70.87, 68.59,
68.49, 67.07, 61.33, 50.63, 20.85, 20.74 (2C), 20.65. MALDI: 438.85 (M+Na) +.
2-Azidoethyl-D-galactopyranoside 8. Compound 7 (2.085 g, 5mmol) was
dissolved in 200 mL NaOCH3 (0.1 M) and stirred at room temperature for 24 h.
After concentration, the resulting residue was dissolved in water (50 mL) and then
neutralized by Amberlite resin. The solvent was removed on a rotary evaporator
to give 8 quantitatively. 1H NMR (500 MHz, CD3OD): δ 4.27-4.25 (dd, 1H),
4.04-3.99 (m, 1H), 3.83-3.81 (dd, 1H), 3.78-3.69 (m, 3H), 3.52 (m, 2H), 3.47 (m,
3H); 13C NMR (125 MHz, CD3OD): δ 105.17, 76.82, 75.00, 72.50, 70.35, 69.27,
62.55, 52.15. MALDI: 272.73 (M+Na) +.
2-Aminoethyl-D-galactopyranoside 9. Pd-C (200 mg) was added to a
solution of 8 (2.085 g, 4 mmol) in water (20 mL), and the mixture was stirred at
room temperature for 24 h under hydrogen atmosphere. After filtration, water was
removed on a rotary evaporator to give 9 as syrup quantitatively. 1H NMR (500
MHz, D2O): δ 4.39 (d, 1H), 3.98-3.94 (m, 1H), 3.90 (d, 1H), 3.78-3.72 (m, 3H),
3.70-3.65 (m, 1H), 3.64-3.60 (dd, 1H), 3.54 -3.49 (dd, 1H), 2.86-2.82 (m, 2H);
13

C NMR (125 MHz, D2O): δ 103.04, 75.32, 72.82,70.96, 70.17, 68.77, 61.14,

40.15. MALDI (M+Na)+: 244.59 (Cal. 246).
Galactosylated macromonomer 10. Galactosylated macromonomer was
prepared via the classical carbodiimide-activated coupling of 5 and 9 (Scheme
2.4).

In the reaction, to a cold solution of 5 (0.5 g, 0.226 mmol) and N-

hydroxysuccinimide (28.6 mg, 0.249 mmol) in methylene chloride (10 mL) was
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added N,N’-dicyclohexylcarbodiimide (56 mg, 0.271 mmol), and the mixture
was reacted at 0 °C for 10 h. The reaction mixture was filtered, concentrated on a
rotary evaporator, and precipitated into cold diethyl ether. The precipitation
process was repeated twice to obtain 10a.
To the solution of 10a in DMF (10 mL) was added 9 (46.3 mg, 0.208 mmol),
and the mixture was reacted at room temperature for 24 h. Then, the reaction
mixture in a cellulose membrane tubing (cut-off molecular weight ~ 500) was
dialyzed against fresh deionized water for 48 h to obtain 10 (70% yield). 1H NMR
(500 MHz, CDCl3): δ 7.37 (d, J = 8.2 Hz, 2H), 7.29 (d, J = 8.2 Hz, 2H), 6.69 (m,
1H), 5.73 (d, J = 17.8 Hz, 1H), 5.22 (d, J = 11.4 Hz, 1H), 4.54 (s, 2H), 5.26 (d, J =
6.9 Hz), 4.00-3.20 (m), 2.56 (m, 4H) ppm;

13

C NMR (125 MHz, CDCl3): δ

174.95, 174.91, 137.94, 137.01, 136.61, 128.04, 126.29, 113.85, 103.67.
Galactosylated nanoparticles. The dispersion copolymerization shown in
Scheme 2.1 was used to prepare the nanoparticles with a polystyrene core and
surface PEG tethers,34 which are terminated with galactose moieties. In a typical
co-polymerization reaction, the macromonomer 10 (0.62 g, 0.26 mmol), styrene
(0.55 g, 5.3 mmol), and the polymerization initiator AIBN (9 mg, 0.055 mmol)
were mixed in ethanol-water mixture (4/1 v/v, 5 mL) in a round flask. Upon
degassing via freeze-thaw cycles, the flask was sealed, and the mixture was stirred
at 60 oC for 24 h to form the nanoparticles. The suspended nanoparticles were
transferred to a cellulose membrane tubing (cut-off molecular weight ~ 12,000)
for dialysis against fresh deionized water for 3 days.
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Experiments with E. coli. The E. coli O157: H7 strain EDL931 was obtained
from Centers for Disease Control and Prevention. The E. coli ORN178 was kindly
provided by Prof. Chun-Cheng Lin of National Taiwan Normal University.29 The
frozen E. coli samples were recovered and cultured in trypticase soy broth. After
overnight incubation at 37 °C, the bacterial culture was harvested and
resuspended in sterile phosphate bufferred saline (PBS, pH 7.4). In a typical
experiment for cell adhesion, the galactosylated polymeric nanoparticles were
suspended in PBS. An aliquot of the suspension was mixed with the E. coli
suspension in PBS for 15 min. The mixture was centrifuged at 8000 g for 5 min,
which resulted in the precipitation of the bacterial cells with any adherent
nanoparticles, while the unbound nanoparticles remained in solution. The
supernatant containing free nanoparticles was discarded, and the pellet was
washed twice with PBS in suspending–centrifuging cycles. The binding of the
galactosylated polymeric nanoparticles with E. coli cells was probed by using
TEM. The sample for the preparation of the TEM specimen was fixed in
cacodylate buffered glutaraldehyde (3.5%, pH ~7.2) at 4 °C for 12 h. A droplet of
the sample was deposited onto a carbon-coated copper grid, stained with uranyl
acetate, and dried in air for 30 min.
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2.2.2 Results and Discussion

Nanoparticle characterization. The galactosylated polymeric nanoparticles
were in a stable aqueous suspension following the dialysis as the final step of the
preparation process. The suspension appeared milky at the original high
concentration but became optically more transparent upon dilution.
Dynamic light scattering (DLS) was used to characterize the nanoparticles in
aqueous suspension. Shown in Figure 2.1 is the DLS result on the particles. The
average diameter of the galactosylated polymeric nanoparticles is around 200 nm,
with a relatively narrow size distribution standard deviation of 16 nm. Since the
DLS measurement was in aqueous suspension, the particle size thus determined
also includes the PEG corona over the polystyrene core (Scheme 2.1). On the
other hand, the dried nanoparticles on a carbon-coated copper grid were analyzed
by SEM. The specimen was prepared by depositing a small drop of the diluted
particle suspension onto the grid, followed by evaporation to remove water. A
typical SEM image of the galactosylated polymeric nanoparticles is shown in
Figure 2.2. By counting the particles on the surface layer in SEM images, the
average particle size and size distribution standard deviation are 178 and 14 nm,
respectively. It is reasonable that the average particle size estimated from SEM is
somewhat smaller than that from DLS measurement, because the PEG corona is
likely shrunken under the conditions for SEM imaging.
The galactosylated polymeric nanoparticles were characterized by several
NMR methods. In these nanoparticles, the particle core is made essentially of
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Size (nm)

Figure 2.1 Dynamic light scattering result of the
galactosylated polymeric nanoparticles in an aqueous
suspension.
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400 nm

Figure 2.2 A typical SEM image of the galactosylated
polymeric nanoparticles.
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linear polystyrene polymers, and the tethered galactoses are pendant functional
groups on the polymers. Thus, the nanoparticles can be dissolved in a solvent
good for both the polystyrene backbones and the pendant galactose moieties,
resulting in a homogeneous solution. Chloroform is such a solvent, so that NMR
measurement was carried out in deuterated chloroform solution. As compared
with that of the macromonomer before polymerization in Figure 2.3, the proton
NMR spectrum of the dissolved nanoparticles is considerably broader (due to
much lower mobility of the polymer chain), with characteristic polystyrene peaks
in 7.2 – 6.1 and 2.3 – 1.2 ppm regions. The PEG signal remains at ~3.65 ppm.
However, the relative concentration of the tethered galactoses is too low to be
detected in the NMR measurement of the nanoparticles in the homogeneous
chloroform solution. According to 1H NMR signal integrations for the PEG and
styrene peaks, the macromonomer mole fraction in the copolymer is on the order
of 5%.
Gel-phase NMR was employed to analyze the nanoparticle-bound galactose
moieties. For the measurement, the nanoparticles were suspended in deuterated
water. Under such a condition, the polystyrene core was in the solid state, thus
contributing no NMR signals.35 Only the hydrophilic tethers and the galactoses
could be detected. The gel-phase proton NMR spectrum of the galactosylated
polymeric nanoparticles is also compared in Figure 2.3. It exhibits no signals from
the polystyrene core, as predicted. The PEG signal at 3.65 ppm is strong and
broad, covering the expected peaks from the tethered galactoses. However, the
overlapping between the PEG and galactose signals is less significant in the gel-
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Macromonomer
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Gel phase NMR
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6

4

2

0

Chemical Shift
Figure 2.3 1H NMR spectra of the galactosylated macromonomer (top) and
the galactosylated polymeric nanoparticles in a homogeneous CDCl3
solution (middle) and in D2O (gel phase NMR, bottom).
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phase 13C NMR spectrum. The peaks due to the tethers at 174 ppm (carbonyl), 39
ppm (-CH2NH-), and 32 ppm (-COCH2CH2CO-) and the galactose carbons at 103
and 62 ppm could be clearly identified. Other galactose carbon signals are still
mixed up with those from the PEG moieties. Nevertheless, the NMR results are
consistent with the nanoparticle structure of a polystyrene core and flexible
surface tethers terminated with galactoses.
Quantification of nanoparticle-bound galactoses. The amount of tethered
galactoses in the nanoparticles was estimated by using the classical anthronsulfuric acid method, which is widely employed in the determination of sugar
content in an analyte based on the oxidation of sugar moieties.28a In the test, the
nanoparticle-bound galactoses were oxidized in an aqueous H2SO4-HCl-formic
acid solution of anthron at 100 °C. The absorbance at 625.5 nm was used for the
quantification in reference to a standard curve. A technical difficulty in the
measurement was due to the scattering effect of the nanoparticle suspension. To
compensate the scattering effect, a suspension of the polymeric nanoparticles
containing no galactoses, but with comparable total particle counts, was used as
the blank. The galactose content in the nanoparticle sample was estimated to be
6.5% (wt/wt). On the other hand, the macromonomer mole fraction in the
copolymer estimated above in terms of solution-phase

1

H NMR signal

integrations puts the galactose content on the order of 4.3% (wt/wt). By using the
average particle diameter from the SEM analysis for the spherical polystyrene
core, with the assumption that the core has the same density as bulk polystyrene
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(1.047 g/cm3), these galactose content values suggest that there are on average 0.8
– 1.3 million tethered galactoses on each particle.
Cell adhesion. The bioactivities of the galactosylated polymeric nanoparticles
were evaluated in terms of their adhesion to several E. coli strains. For the
pathogenic E. coli O157: H7, as an example, the bacterial cells in PBS were
mixed with the suspended nanoparticles, followed by centrifuging to separate the
cells from free nanoparticles in the supernatant. The pellet was washed repeatedly
with PBS through a suspending –centrifuging routine. The interactions of the
galactosylated polymeric nanoparticles with E. coli O157: H7 cells were
visualized in TEM analyses. Shown in Figure 2.4 is a typical TEM image of the
sample. The galactosylated polymeric nanoparticles are apparently bioactive,
binding with multiple E. coli cells to result in significant cell agglutination. This
is consistent with the report that there are periplasmic galactose-binding proteins
on the E. coli cell that couple with galactose ligands.36
The E. coli ORN178 strain is known to contain receptors toward Dmannoses.29 Interestingly, however, the galactosylated polymeric nanoparticles
can also bind with E. coli ORN178. The TEM image in Figure 2.5 shows that an
E. coli cell is surrounded by a large number of the nanoparticles. This could not
be a result of simple adsorption because no binding was observed with the use of
bare polymeric nanoparticles without the galactose moieties.
Multivalent carbohydrate ligands carried on linear and branched polymers
ordendrimers are more potent than their monovalent counterparts in cell
adhesion.12,17,28,37-41 The results reported here show that polymeric nanoparticles
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are also very effective in the display of multivalent ligands for interactions with
specific cell adhesions. The nanoparticles are easily imaged in microscopy
analyses, allowing the visualization of the interactions. In addition, the polymeric
nanoparticles displaying galactoses and other bioactive ligands may also be
developed as potent inhibitors or effectors for specific cellular responses.
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400 nm

Figure 2.4 A TEM image showing the agglutination of E. coli
O157:H7 cells mediated by the galactosylated polymeric
nanoparticles.
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400 nm

Figure 2.5 A TEM image showing an E. coli ORN178 cell bound by
many galactosylated polymeric nanoparticles.
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2.3 Mannosylated Polymeric Nanoparticles

2.3.1 Experimental Section
Materials. D-mannose was obtained from Alfa Aesar. All the others are the
same as those in Part I of this Chapter. Mannosylated macromonomer was
synthesized in terms of procedures shown in Scheme 2.2, Scheme 2.5, and
Scheme 2.6.
1,2,3,4,6-Penta-O-acetyl mannopyranoside 11. A solution of D-mannose
(15.0 g, 83.3 mmol) in anhydrous pyridine (70 mL) was placed in an ice bath,
followed by dropwise addition of acetic anhydride (100 mL, 1058.8 mmol).
Stirring was continued for 1 h at 0 °C, then at room temperature (12 h). Pyridine
and excessive acetic anhydride were removed on a rotary evaporator and
chloroform (70 mL) was added. The mixture was washed with cold water (10
mL*3), aqueous sodium hydrogencarbonate (5%, 10 mL), cold water (10 mL).
The organic phase was dried over anhydrous MgSO4. After filtration, the solvent
was removed on a rotary evaporator to give compound 11 (29.2g, 90% yield). 1H
NMR (500 MHz, CDCl3): * 2.0-2.3 (m, 15H), 4.0-4.2 (m, 2H), 4.2-4.4 (m, 1H),
5.1-5.5 (m, 3H), 6.08 (d, J = 1.85 Hz, 1H) ppm;

13

C NMR (125 MHz, CDCl3):

* 20.00-22.00(m), 62.02, 65.44, 68.28, 68.71, 70.54, 90.53, 168.00, 169.65,
169.69, 169.92, 170.55 ppm.
2-Chloroethyl 2,3,4,6-tetra-O-acetyl-D-mannopyranoside 12. To a cooled
(ice-water), stirred solution of 11 (13.5 g, 34.6 mmol) and 2-chloroethanol (4.18
g, 51.9 mmol) in anhydrous dichloromethane (60 mL) was added BF3-etherate (22
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Scheme 2.5 Synthesis 2-aminoethyl-α-D-mannopyranoside 15.
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Scheme 2.6 Synthesis mannosylated macromonomer 16.
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mL, 173 mmol) dropwise. Stirring was continued for 1 h at 0 °C, then at room
temperature (12 h). The mixture was worked up using the same procedure as 11 to
give 12 (12.7g, 90% yield). 1H NMR (300 MHz, CDCl3): * 2.0-2.3 (m, 12H),
3.70 (t, J = 5.54 Hz, 2H), 3.80-3.97 (m, 2H), 4.00-4.16 (m, 2H), 4.25-4.35 (m,
1H), 4.89 (d, J = 1.42 Hz, 1H), 5.22-5.37 (m, 3H) ppm;

13

C NMR (75 MHz,

CDCl3): * 20.00-22.00(m), 42.40, 62.36, 65.95, 68.56, 68.87, 69.35, 97.75,
169.69, 169.78, 169.92, 170.52 ppm.
2-Azidoethyl 2,3,4,6-tetra-O-acetyl-D-mannopyranoside 13. To a solution
of 12 (12.7g, 30.9 mmol) and tetrabutylammonium bromide (0.2 g, 0.6 mmol) in
DMF (50 mL) was added sodium azide (20 g, 309 mmol). The system was kept at
65 °C for 12 h. DMF was removed on a rotary evaporator, and re-dissolved in
chloroform (50 mL). The organic phase was washed by water (10 mL*3) and
dried over anhydrous MgSO4. After filtration, the solvent was removed to give 13
(12.6g, 98% yield). 1H NMR (500 MHz, CDCl3): * 1.9-2.3 (m, 12H), 3.47 (m,
2H), 3.70 (m, 1H), 3.88 (m, 1H), 4.10 (m, 2H), 4.30 (m, 1H), 4.90 (d, J = 1.41 Hz,
1H), 5.28-5.40 (m, 3H) ppm;

13

C NMR (125 MHz, CDCl3): * 20.00-22.00 (m),

50.37, 62.47, 65.97, 67.08, 68.84, 68.89, 69.38, 97.74, 169.82, 169.88, 169.96,
170.69 ppm.
2-Azidoethyl-D-mannopyranoside 14. Compound 13 (5.0 g, 12 mmol) was
dissolved in 500 mL NaOCH3 (0.1 M) and stirred at room temperature for 24 h.
After concentration, the resulting residue was dissolved in water (100 mL) and
then neutralized by Amberlite resin. The solvent was removed on a rotary
evaporator to give 14 quantitatively. 1H NMR (500 MHz, D2O): * 3.40-3.56 (m,

65

2H), 3.60-3.78 (m, 4H), 3.80-3.83 (m, 1H), 3.84-3.93 (m, 2H), 3.95 (m, 1H), 4.89
(d, J = 1.85 Hz, 1H) ppm;

13

C NMR (125 MHz, D2O): * 50.35, 61.07, 66.46,

66.84, 70.08, 70.54, 73.06, 99.97 ppm.
2-Aminoethyl-D-mannopyranoside 15. To a solution of 14 ( 5 g, 10 mmol)
in water (50 mL), Pd-C ( 200 mg) was added, the mixture was degassed under
vacuum with stirring, refilled with hydrogen, and stirred for 12 h. Pd-C was
removed by filtration, and water was removed on a rotary evaporator to give 15 as
a syrup quantitatively.

1

H NMR (500 MHz, D2O): * 2.70-2.90 (m, 2H), 3.40-

4.00 (m, 8H), 4.86 (d, J = 1.04 Hz, 1H) ppm;

13

C NMR (125 MHz, D2O):

* 40.05, 61.10, 66.86, 68.84, 70.15, 70.66, 72.86, 100.08 ppm.
Mannosylated macromonomer 16. The macromonomer 16 was prepared via
the classical carbodiimide-activated coupling of 5 and 15 (Scheme 2.6). In the
coupling reaction, to a cold solution of 5 (0.5 g, 0.226 mmol) and Nhydroxysuccinimide (0.0286 g, 0.249 mmol) in methylene chloride (10 mL) was
added N,N’-dicyclohexylcarbodiimide (0.056 g, 0.271 mmol), and the mixture
was reacted at 0 ºC for 10 h. The reaction mixture was filtered, concentrated on a
rotary evaporator, and precipitated into cold diethyl ether. The precipitation
process was repeated to obtain 16a (87% yield). 1H NMR (500 MHz, CDCl3):
* 7.34 (d, J = 8.20 Hz, 2H), 7.26 (d, J = 7.22 Hz, 2H), 6.64 (m, 1H), 5.70 (d, J =
18.30 Hz, 1H), 5.19 (d, J = 11.9 Hz, 1H), 4.50 (s, 2H), 3.3-3.90 (m), 2.93 (t, J =
7.1 Hz, 2H), 2.78 (s, 4H), 2.56 (t, J = 7.32 Hz, 2H) ppm;

13

C NMR (125 MHz,

CDCl3): * 170.03, 169.09, 168.34, 137.94, 136.98, 136.60, 128.00, 126.26,
113.83, 72.98, 68.00-72.00 (m), 39.48, 30.43, 26.76, 25.62 ppm.
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To a solution of 16a (0.4 g, 0.173 mmol) in DMF (10 mL) was added 15
(0.0463 g, 0.208 mmol), and the mixture was reacted at room temperature for 24
h. Then, the reaction mixture in a cellulose membrane tubing (cut-off molecular
weight ~ 500) was dialyzed against fresh deionized water for 48 h to obtain 16
(80% yield). 1H NMR (500 MHz, CDCl3): * 7.40 (d, J = 8.20 Hz, 2H), 7.34 (d, J
= 7.80 Hz, 2H), 6.72 (m, 1H), 5.76 (d, J = 18.30 Hz, 1H), 5.26 (d, J = 11.9 Hz,
1H), 4.58 (s, 2H), 3.40-3.90 (m, 180H), 2.67 (t, J = 7.30, 2H), 2.56 (t, J = 6.85
Hz, 2H) ppm;

13

C NMR (125 MHz, CDCl3): * 174.95, 174.91, 137.51, 137.20,

136.47, 129.04, 126.58, 114.79, 99.85, 68-76 (m), 67.00, 66.00, 61.10, 39.11,
31.22 ppm.
Mannosylated nanoparticles. In a typical reaction, the macromonomer 16
(0.62 g, 0.26 mmol) and styrene (0.55 g, 5.3 mmol) were mixed with the
polymerization initiator AIBN (9 mg, 0.055 mmol) and the ethanol-water mixture
(4/1, 5 mL) in a round flask. Upon degassing via freeze-thaw cycles, the flask was
sealed and the mixture was stirred at 60 oC for 24 h. The suspension of
nanoparticles formed in the polymerization reaction was transferred to a cellulose
membrane tubing (cut-off molecular weight ~ 12,000) for dialysis against fresh
deionized water for 3 days.
E. coli samples. E. coli strains ORN178 and ORN208 were kindly provided
by Dr. Chu-Cheng Lin, Institute of Chemistry, Academia Sinica, Taiwan.29 The
two frozen E. coli samples were recovered and cultured in trypticase soy agar.
After overnight incubation at 37 oC, the bacterial culture was harvested and
suspended in phosphate buffer saline (PBS).
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Measurements. NMR measurements were performed on a JEOL Eclipse
+500 NMR spectrometer. Dynamic light scattering characterization was carried
out on a Coulter N4 Plus particle sizer. Transmission electron microscopy (TEM)
analyses were conducted on a Hitachi HD-2000 TEM/STEM system equipped
with a CCD camera for digital imaging.

2.3.2 Results and Discussion
The D-mannose functionalized nanoparticles (Scheme 2.7) were prepared in
the dispersion copolymerization of the mannosylated macromonomer with
styrene.34 The nanoparticles thus prepared form a stable suspension in water,
which allows characterization by using the dynamic light scattering (DLS)
technique. The DLS result shows that the suspended polymeric nanoparticles have
an average diameter of ~160 nm. This is confirmed by the result from TEM
imaging of the same sample deposited on a carbon-coated copper grid (Figure
2.6).
In the study of adhesion interactions of the D-mannose functionalized
polymeric nanoparticles with E. coli ORN178 (expressing wild-type 1 pili), the
bacterial suspension in PBS was mixed with an aqueous suspension of the
mannosylated nanoparticles for 5 min, and then the mixture was centrifuged at
6,000 × g for 3 min. The supernatant containing free nanoparticles was removed,
and the pellet was washed with PBS, centrifuged, and then re-suspended in PBS
(1 mL). The sample for TEM imaging was fixed in cacodylate buffered
glutaraldehyde (3.5%, pH ~ 7.2) at 4 oC for 12 h. A droplet of the sample was
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Scheme 2.7 Structure of mannosylated polymeric nanoparticles.
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200 nm

Figure 2.6 A TEM image of the mannosylated polymeric nanoparticles.
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400 nm

Figure 2.7 An E. coli ORN178 cell is bound a large number of the
mannosylated polymeric nanoparticles.
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deposited on a carbon-coated copper grid, stained with uranyl acetate, and then
dried in air for 30 min. The TEM image in Figure 2.7 shows the binding of a large
number of nanoparticles with an E. coli ORN178 cell. The result suggests that the
mannosylated polymeric nanoparticles have strong adhesion interactions with the
E. coli strain.
The relative sizes of the nanoparticles to the bacterial cells and the large
number of nanoparticle surface-tethered mannose functionalities enable some of
the nanoparticles each bind with more than one E. coli cell. As a result, there is
significant agglutination of multiple E. coli cells. As shown in Figure 2.8, the
agglutination mediated by the mannosylated polymeric nanoparticles is easily
observed in the electron microscopy images.
The agglutination of E. coli ORN178 cells mediated by mannosylated
nanoparticles was also visualized by SEM (Figure 2.9). Both the lower and higher
magnification images clearly show the attachment of nanoparticles on the surfaces
of E. coli cells.
The binding of the nanoparticles to E. coli cells and the resulting significant
cell agglutination are associated with the specific adhesion interactions, for which
the nanoparticle-bound D-mannose molecules are required.

In a control

experiment, no agglutination was observed with the use of bare polymeric
nanoparticles with the polyethylene glycol tethers but without the derivatized Dmannose molecules (Scheme 2.7) under otherwise the same experimental
conditions. The corresponding TEM image shows no meaningful difference from
that of the suspended free E. coli ORN178 (Figure 2.10a).
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500 nm

Figure 2.8 Lower magnification (a,b) and higher magnification (c,d) TEM
images (dark-field) showing the agglutination of E. coli ORN178 mediated by
D-mannose-tethered polymeric nanoparticles.
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a

1500 nm

b

600 nm

Figure 2.9 SEM images showing the agglutination of E. coli
ORN178 mediated by mannosylated nanoparticles. (a) low
magnification and (b) high magnification.
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a

3 µm

b

3 µm

Figure 2.10 (a) A TEM image of the specimen prepared from E. coli
ORN178 suspended in PBS buffer. (b) A TEM image of the specimen from
the experiment of E. coli ORN208 with D-mannose-tethered polymeric
nanoparticles under the same experimental conditions as those for Figure
2.8.
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The binding interactions responsible for the significant agglutination are also
cell adhesin specific. In another control experiment, E. coli ORN208 (deficient of
the fimH gene and expressing abnormal type 1 pili without specific binding with
D-mannose) instead of E. coli ORN178 was used for evaluation under the same

experimental conditions.

The mannosylated polymeric nanoparticles hardly

interact with this E. coli strain, resulting in no meaningful cell agglutination
(Figure 2.10b).
The binding interactions of the mannosylated polymeric nanoparticles with E.
coli ORN178 are strong. In an experiment to compare the competitive binding
abilities of the nanoparticle-tethered D-mannose moieties and the free D-mannose
molecules to the E. coli cells, the mannosylated nanoparticles and a free Dmannose solution (10 mg/mL) were incubated with the bacterial suspension.
According to TEM analyses, there was significant binding of the nanoparticles to
bacteria, with the same agglutination. The results suggest that the nanoparticlebound D-mannose moieties are more competitive than free D-mannose molecules
in the multivalent adhesion interactions with the E. coli cells.
Similarly, the agglutinated E. coli cells by the mannosylated polymeric
nanoparticles could not be dissociated by a subsequent incubation with a solution
of free D-mannose molecules (10 mg/mL). In the literature, however, D-mannose
solutions of comparable concentrations have been shown to inhibit the E. coli yeast agglutination.6
The mannosylated polymeric nanoparticles are obviously effective in the
agglutination of E. coli ORN178 via adhesin-specific interactions, and the
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nanoparticles-mediated agglutination is conveniently detected in conventional
electron microscopy. However, in addition to providing a unique platform for the
visualization of the cell agglutination, the mannosylated polymeric nanoparticles
may potentially serve as therapeutic agents for the inhibition of enteropathogenic
infections. It is known that the adherence of enterotoxigenic E. coli on intestinal
epithelium is an important step in the infectious process. This adherence depends
on binding between the bacterial specific adhesins (adhesive surface molecules on
fimbria, pili or outer membranes) and the receptors (protein, glycoprotein, or
glycolipid) on microvillous membranes of absorptive cells.4,5 It has also been
shown that soluble D-mannose inhibits the adhesion of some enteropathogens to
animal and human intestinal cells.6-10 With the strong adhesion interactions of the
mannosylated polymeric nanoparticles with E. coli and the resulting significant
cell agglutination, more effective inhibition might be expected from these
nanoparticles. Further investigations on potential inhibition applications are
planned.

2.4 Conclusion

Polymeric nanoparticles of a polystyrene core and oligomeric PEG-based
tethers can be prepared via dispersion copolymerization of styrene with
specifically synthesized macromonomer. The tethers can be used to carry
covalently derivatized galactose/mannose moieties, and the particle surface
functionalities can be characterized by using NMR and other techniques. The
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galactosylated and mannosylated polymeric nanoparticles are bioactive,
exhibiting significant adhesion interactions with several E. coli strains. The
reported work demonstrates that polymeric nanoparticles may serve as a versatile
vehicle for the delivery or display of biofunctional groups in potential biological
and biomedical applications.
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CHAPTER 3
POLY(ETHYLENE GLYCOL)-COATED MAGNETIC POLYMER
NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND THEIR
APPLICATIONS

3.1 Introduction
Magnetic nanoparticles have received much attention in the past few years for
their extensive use in such biomedical applications as target drug delivery,1
magnetic resonance imaging (MRI),2 cell separation,3 immunoassays,4 nucleic
acid purification,5 DNA separation,6 enzyme immunization.7 To satisfy these
biomedical applications, magnetic nanoparticles must be able to fulfill certain
criteria: no sedimentation, a uniform size and narrow size distribution, high and
uniform magnetic content, superparamagnetic behavior, no iron leakage,
biocompatibility, and high density of surface functional groups.8
Magnetic polymer nanoparticles (MPNPs), nanoparticles with external
polymer shells, have generated much recent research efforts, because the
methologies for the encapsulation of iron oxide nanoparticles in hydrophobic
polymers is of fundamental interest, regarding the expansion of their use.9,10 A
straightforward method for encapsulation involves the coating or encapsulation of
magnetic nanoparticles with preformed natural or synthetic polymers either
physically or chemically.11 MPNPs can also be obtained from the in situ
precipitation of magnetic nanoparticles in the presence of polymer which acts as a

stabilizer. For example, Ugelstad and coworkers prepared monodisperse MPNPs
by the precipitation of magnetic oxides inside preformed porous mono-sized
polymer nanoparticles in situ.12,13 Many other processes developed for use in
polymer

encapsulation

of

magnetic

nanoparticles

include

emulsion

polymerization,14 seed polymerization,15 dispersion polymerization,16 suspension
polymerization,17 atom transfer radical polymerization (ATRP),18,19 and
miniemulsion polymerization.10,21,22 Among these processes, miniemulsion
polymerization, which involves the encapsulation of inorganic particles into
polymers, has been the focus of recent polymerization research.
In miniemulsion polymerization,23 miniemulsions are understood to be stable
aqueous dispersions of monomer droplets with sizes of ~50-500 nm. These may
be prepared by shearing a mixture of monomer, water, a surfactant, and a highly
water insoluble compound - the so-called hydrophobe which is used to suppress
Ostwald ripening of the droplets. Both the particle nucleation and propagation
reaction occur primarily in these highly stable submicrometer monomer droplets,
each of which may be viewed as individual nano-phase reactors. After
polymerization, these droplets are polymerized without changing their identity.
For successful encapsulation, the inorganic particles used are required to be
hydrophobic for their preferable dispersion in hydrophobic monomer droplets. For
example, following their report on the encapsulation of CaCO324 and carbon
black25 into polystyrene particles, Landfester et al. similarly encapsulated high
amounts of magnetite into the same polymer particles through a three-step
preparation route which included two miniemulsion processes.8 In a somewhat

82

indirect approach, Gu et al.21 prepared a stable water-based dispersion of
SDS/oleic acid bilayer coated magnetite aggregates for mixing with monomer
styrene miniemulsion. MPNPs, with uniform magnetite encapsulation, were
created by sonicating the mixture followed by polymerization. Recently, Forcada
et al.22 also prepared MPNPs by miniemulsion polymerization of the oil-based
styrene magnetite ferrofluid, using hexadecane as the hydrophobe, 2, 2’azobisisobutyronitrile as the initiator, sodium dodecyl sulfate as the emulsifier,
and methacrylic acid as a comonomer.
There are several concerns that arise when using these as-produced MPNPs
for biomedical applications.26,27 First, the surfactants may be physically adsorbed
onto the MPNPs surfaces, resulting in their destabilization. Secondly, because of
their large surface area/volume ratio, the MPNP surfaces are highly susceptible to
non-specific plasma proteins adsorption. Thirdly, during the polymerization
process, a large amount of functional groups became buried in the polymer with
only a small part left on the surface.
Since surfaces covered with poly(ethylene glycol) (PEG) have proven to be
nonimmunogenic, nonantigenic, and protein resistants,28 the introduction of PEG
chains onto nanoparticle surfaces is obviously beneficial for use in biomedical
applications because they have none of the disadvantages of the nanoparticles
with such surface modifications.29 In the procedures detailed in this chapter,
miniemulsion polymerization was applied to prepare hydrophilic MPNPs
(Scheme 3.1) by using macromonomer 1 and 2 (Figure 3.1). These PEG-coated
MPNPs were characterized using various instrumental techniques, such as NMR,
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SEM, TEM, SQUID, TGA, at el. Our collaborators also detected L.
monocytogenes in artificially contaminated milk, with the subsequent results
suggesting that these MPNPs have more advantageous use in practical
commercial applications than the commercially available Dynabeads currently in
use.30a Furthermore, these PEG-coated MPNPs have been demonstrated to be as a
good magnetic resonance imaging (MRI) agent as Ferumoxides injectable
solution, the first liver-specific MRI enhancement agent.30b
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Scheme 3.1 TEM picture of polymer coated magnetic nanoparticles.
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Figure 3.1 Structure of Macromonomer 1 (a) and Macromonomer 2 (b).
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3.2 Experimental Section

Materials. NaH (60%, dispersed in mineral oil), FeCl3.6H2O, FeCl2.4H2O,
hexadecane (99%) and 4-vinylbenzyl chloride (90%) were purchased from the
chemical supplier Acros Organics. Polyethylene glycol (Mn ~ 2000), tert-butyl
bromoacetate (98%), iron (0) pentacarbonyl (99.999%), oleic acid (~99%),
dioctyl

ether

(99%),

trimethylamine

N-oxide

(98%),

2,

2'-azobis(2-

methylpropionitrile) (AIBN, 98%) and styrene (99%) were obtained from SigmaAldrich. Tetrahydrofuran (THF) and other solvents were obatined from
Mallinckrodt. THF was distilled over sodium before use. Deuterated solvents for
NMR measurement were supplied by Cambridge Isotope Laboratories.
Measurements. NMR measurements were performed on a JEOL Eclipse
+500 NMR spectrometer. Thermogravimetric analysis (TGA) was carried out on
a Mettler-Toledo TGA/SDTA851e system. Scanning electron microscopy (SEM)
images were obtained on a Hitachi S4700 field-emission SEM. Transmission
electron microscopy (TEM) images were obtained using Hitachi 7000 and Hitachi
HF-2000 TEM instruments. X-ray powder diffraction measurements were
performed on a Scintag XDS-2000 system. A Quantum Design MPMS
superconducting quantum interference device (SQUID) magnetometer was used
to determine the magnetic properties of both iron oxide and polystyrene
encapsulated magnetic nanoparticles at room temperature between 50 kOe.
Synthesis of macromonomer 1. The structure of macromonomer 1 is shown
in Figure 3.1. Synthesis details of macromonomer 1 are described in Chapter 2.
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Synthesis of macromonomer 2. Macromonomer 2 (Figure 3.1) was
synthesized according to the following procedure, as shown in Scheme 3.2. NaH
(~60%, 0.48 g, 12 mmol) was added to a 120 mL THF solution of polyethylene
glycol (10 g, 5 mmol) at room temperature. The mixture was stirred for
approximately 30 minutes and 4-vinylbenzyl chloride (0.84 g, 5 mmol) was added
dropwise. The mixture was again stirred for 12 h at constant temperature of 35 oC.
tert-Butyl bromoacetate (2 g, 10 mmol) was then added dropwise to the above
mixture and stirred at 35 oC overnight. Upon the removal of insoluble salts via
filtration, the filtrate was concentrated and precipitated into cold ether. The
precipitants were then collected and dried in a vacuum oven at room temperature
to obtain the macromonomer 2 (9.5 g, 85% yield). 1H NMR (500 MHz, CDCl3): δ
7.40 (d, J = 8.2 Hz, 2 H), 7.34 (d, J = 7.8 Hz, 2 H), 6.27 (m, 1 H), 5.76 (dd, J =
18.4, 0.9 Hz, 1 H), 5.24 (dd, J = 10.1, 0.9 Hz, 1 H), 4.58 (s, 2 H), 3.95 (s, 2H),
3.90–3.40 (m, 180 H), 1.5 (s, 9) ppm.

13

C NMR (125 MHz, CDCl3): δ 169.72,

137.93, 136.97, 136.58, 128.00, 126.25, 113.81, 81.55, 72.97, 72.00-70.00 (m),
69.43, 69.06, 28.17 ppm.
Synthesis of Fe3O4 (magnetite) nanoparticles. Oleic acid-stabilized Fe3O4
magnetic nanoparticles were prepared by a conventional coprecipitation method
with some modifications, as shown in Scheme 3.3. FeCl3.6H2O (11.6 g, 42.8
mmol) and FeCl2.4H2O (4.3 g, 21.5 mmol) were dissolved in 400 mL of
deionized water under nitrogen gas protection with vigorous stirring at 85 °C.
NH3.H2O (25%; 15 mL) was added first to the solution, and then 9 mL of oleic
acid was added dropwise into suspension within 20 min. After 10 minutes, the
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Scheme 3.2 Synthesis of Macromonomer 2.
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NH3.H2O
oleic acid
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Scheme 3.3 Synthesis route of Fe3O4 nanoparticles.
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magnetic precipitate was isolated from the solvent by magnetic decantation. The
precipitate was then washed with deionized water 3 times to remove the excessive
oleic acid, and the magnetic precipitate was re-dispersed in hexane to form
magnetic fluid.
Synthesis of γ-Fe2O3 (maghemite) nanoparticles. Monodisperse γ-Fe2O3
nanoparticles were prepared following a standard procedure pioneered by Hyeon
et al. that has been previously detailed in the literature, as shown in Scheme 3.4.31
To prepare monodispersed γ-Fe2O3 nanoparticles, 0.2 mL of Fe(CO)5 (1.52 mmol)
was added to a mixture containing 10 mL of octyl ether and 1.28 g of oleic acid
(4.56 mmol) at 100 oC. The resulting mixture was heated to reflux and kept at that
temperature for 1 h, during which time, the initial orange color of the solution
gradually changed to black. The resulting black solution was cooled to room
temperature and 0.34 g of dehydrated (CH3)3NO (4.56 mmol) was added. The
mixture was then heated to 130 oC under an argon atmosphere and maintained at
this temperature for 2 h, whereupon it formed a brown solution. The reaction
temperature was slowly increased to reflux and the reflux continued for 1 h,
during which time the color of the solution gradually turned from brown to black.
The solution was then cooled to room temperature, and ethanol was added to yield
a black precipitate, which was then separated by centrifuging. The resulting black
powder was able to be easily re-dispersed in such hydrocarbon solvents as
hexane, octane, and toluene.
Synthesis of Fe3O4-encapsulated polymeric nanoparticles (I). Fe3O4
nanoparticles were encapsulated in polystyrene particles by a miniemulsion
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polymerization process, as shown in Scheme 3.5. 0.3 g Fe3O4 nanoparticles, 100
mg AIBN and 0.12 g hexadecane, for use as an osmotic agent, were dissolved in 3
g styrene to form the oil phase; 1.5 g of macromonomer 2 and 100 mg SDS were
dissolved in 24 mL H2O to form the aqueous phase. After removing air by N2,
these solutions were mechanically mixed and stirred for 1 h. To prevent
polymerization, the miniemulsion was prepared by ultrasonicating the emulsion
for 10 min at 0 oC. To initiate polymerization, the temperature was increased to 65
o

C and maintained for 4 h. A magnetic separator was used to harvest the particles

containing the Fe3O4.
Synthesis of γ-Fe2O3–encapsulated polymeric nanoparticles (II). γ-Fe2O3
nanoparticles were also encapsulated in a polystyrene particles by a miniemulsion
polymerization process, as shown in Scheme 3.5. Specifically, 0.3 g γ-Fe2O3
nanoparticles, 100 mg 2, 2’-azobis(2-methylbutyronitrile) and 0.12 g hexadecane,
again employed as an osmotic agent, were dissolved in 3 g styrene to form the oil
phase; 1.5 g of macromonomer 2 and 100 mg SDS were dissolved in 24 mL H2O
to form the aqueous phase. After removing air by using N2, these two solutions
were mixed and stirred for 1 h. To prevent polymerization, the miniemulsion was
prepared by ultrasonicating the emulsion for 10 min at 0 oC. To initiate
polymerization, the temperature was increased to 65 oC and maintained at this
temperature for 4 h. A magnetic separator was again used to harvest the particles
containing the γ-Fe2O3 nanoparticles.
Synthesis

of

γ-Fe2O3–encapsulated

polymeric

nanoparticles

with

carboxylic acid (III). The same procedure was employed as that used to

92

Fe(CO)5 + Oleic acid + Octyl ether
heating

Fe nanoparticle

(CH3)3NO

γ-Fe2O3
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Scheme 3.4 Synthesis route of γ-Fe2O3 nanoparticles.
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Scheme 3.5 Procedure for the encapsulation of magnetic nanoparticles
in polymer particles by miniemulsion polymerization, including the
following processes: 1. addition of water and surfactants; 2. mechanical
stirring and sonication; 3. polymerization.

94

synthesize the γ-Fe2O3–encapsulated polymeric nanoparticles (II), except that
macromonomer 1 was used rather than macromonomer 2.
Preparation of carboxylic acid-functionalized magnetic nanoparticles
(IV). The carboxylic acid-functionalized magnetic polymer nanoparticles were
obtained through the hydrolysis of γ-Fe2O3–encapsulated polymeric nanoparticles
(II), as shown in Scheme 3.6. Specifically, sodium methoxide was added to a
dispersion of magnetic polymeric nanoparticles (II) in water to adjust the pH
value to 10. The resulting suspension was stirred at room temperature for 8 h. A
magnetic separator was used to harvest the carboxylic acid-functionalized
magnetic nanoparticles (IV) and washed with water three times.
Applications. The γ-Fe2O3–encapsulated polymeric nanoparticles (IV) were
used in the rapid detection of Listeria monocytogenes by our collaborator Dr.
Xiuping Jiang and Dr. Hua Yang in the Department of Food Science and Human
Nutrition at Clemson University and as MRI contrast agents for in vitro
application by our collaborator Dr. Jian-Ming Zhu at Wake Forest University,
School of Medicine. More experimental details are available in Dr. Hua Yang’s
dissertation32 and ref. 42.

95

γ-Fe2O3

n

O
O

O

O

m

γ-Fe2O3

n

O
O

(IV)

O
m

OH

Scheme 3.6 The preparation of carboxylic acid-functionalized
magnetic nanoparticles (IV) from γ-Fe2O3-encapsulated polymeric
nanoparticles (II).
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3.3 Results

Synthesis of Fe3O4 nanoparticles. Fe3O4 nanoparticles were obtained in a
co-precipitation process by quickly adding a concentrated ammonium solution to
a solution of Fe2+/Fe3+ with a molar ratio of 1:2 (Scheme 3.3). By adding oleic
acid at temperatures above its melting temperature, the Fe3O4 nanoparticles were
hydrophobized and were able to be easily dispersed in organic solvents such as
hexane, octane and toluene. The morphological characteristics of those Fe3O4
nanoparticles were observed by TEM, as shown in Figure 3.2. The size of the
nanoparticles ranged from 10 and 15 nm.
Synthesis of γ-Fe2O3 nanoparticles. Highly crystalline and monodisperse
magnetic γ-Fe2O3 nanoparticles were synthesized according to the procedure
outlined in Scheme 3.4,31 illustrating that the nanoparticles possess a oleic acid
ligand shell around the inorganic γ-Fe2O3 core. The nanoparticles obtained were
characterized by TEM, X-ray powder diffraction, TGA and SQUID.
The synthesized oleic acid-coated maghemite nanoparticles were able to be
spontaneously dispersed into hexane, forming a very stable dispersion. The
formation of acid-coated maghemite nanoparticles and their average size and size
distributions were investigated by both scanning electron microscopy (SEM) and
transmission electron microscopy (TEM). The SEM specimen was prepared by
depositing a small drop of maghemite nanoparticles in hexane onto a SEM sample
holder, followed by the evaporation of the solvent. The TEM specimen was
prepared by depositing a small drop of maghemite nanoparticles in hexane onto a
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carbon-coated copper grid, followed by the evaporation of the solvent. Figure 3.3a
and Figure 3.3b show respective SEM and TEM images of the oleic acid-coated
maghemite nanoparticles. Both SEM and TEM results also indicate that all
particles are well dispersed and have a narrow size distribution with an average
diameter of 6.0 nm (Figure 3.3c). The X-ray powder diffraction pattern of the
nanoparticles, shown in Figure 3.4, elucidate the nature highly crystalline
structure. The position and relative intensity of all diffraction peaks match quite
well with those of the standard γ-Fe2O3 reflections, as compared with (γ-Fe2O3,
Powder Diffraction file, JC-POS 39-1346). Additional thermogravimetric analysis
quantified the γ-Fe2O3 content in oleic acid-coated nanoparticles. Figure 3.5,
detailing the TGA of the dried oleic acid-coated magnetite particles, shows a 33%
loss in weight of organic materials at temperature up to 450 οC. The weight loss
then ceased and remained constant at temperatures beyond this range, and up to
500 οC. This temperature variance indicated that the particles contained 67 wt.%
maghemite.
Magnetic susceptibility of γ-Fe2O3 powder samples were measured using a
Quantum Design MPMS-5S SQUID magnetometer. Samples were placed inside a
gelatin capsule, which was suspended in a plastic drinking straw attached to the
sample transport drive. The magnetic susceptibility of the container was
previously determined and its effects accounted for in data manipulation.
Magnetic data were also corrected for core diamagnetism, and the hysteresis loops
of the magnetic nanoparticle samples were recorded. As shown in Figure 3.6, the
magnetization curves reached the saturation of 55.7 emu/g meghmite when the
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Figure 3.2 TEM images of Fe3O4 nanoparticles.
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Figure 3.3 SEM (a) and TEM (b) of oleic acid-coated iron oxide
and its size distribution (c).
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Figure 3.4 Powder X-ray diffraction patterns of magnetic polymer
nanoparticles (top) and oleic acid-coated iron oxide nanoparticles
(middle). The γ-Fe2O3 pattern from the JCPDS database (bottom) is
also shown for reference.
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Figure 3.5 TGA of oleic acid-coated iron oxide (dashed) and
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Figure 3.6 Magnetic behavior of oleic acid-coated iron oxide (dashed) and
MPNPs (solid).
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applied magnetic fields increased to 5000 Oe, which is lower than the bulk
meghemite value of 74 emu/g meghemite. The subsequent reduction in
magnetization may be the result of surface effects.34,35 However, There was
almost no noticeable hysteresis observed in the magnetization curves, suggesting
that the oleic acid-coated maghemite nanoparticles are superparamagnetic, in the
absence of both coercivity and remanence.36
Synthesis of Fe3O4-encapsulated polymer nanoparticles (I). A multi-step
process was developed in order to obtain the magnetic polymer nanoparticles. A
solution of Fe3O4 nanoparticles in styrene was initially added to an aqueous
solution containing macromonomer and surfactant SDS. This mixture was then
pre-emulsified and co-sonicated to form a stable miniemulsion of the
monomer/magnetic nanoparticle dispersion in water. Lastly, this stable
miniemulsion was polymerized at 65 °C to form polymer nanoparticles with
magnetite cores, as shown in Scheme 3.5, which was verified by TEM, as shown
in Figure 3.7. TEM also determined that the Fe3O4 nanoparticles occured as
clumps within the polystyrene nanoparticles.
Synthesis of γ-Fe2O3-encapsulated polymer nanoparticles (III). To
introduce carboxylic acids directly to the surface of magnetic polymer
nanoparticles, carboxylic acids-containg macromonomer 1 was used for the
miniemulsion polymerization. The resulting γ-Fe2O3-encapsulated polymer
nanoparticles (III) were characterized by TEM as shown in Figure 3.8, elucidating
the encapsulation of the resulting maghemite nanoparticles, which were pretty
uniform in size. However, the surfaces of the resulting γ-Fe2O3-encapsulated
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Figure 3.7 TEM images of Fe3O4-encapsulated polymer
nanoparticles.
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200 nm

Figure 3.8 TEM of MPNPs made from Macromonomer 1.

106

polymer nanoparticles (III) were also covered by maghemite nanoparticles, which
may be attributed to the interaction of carboxylic acids and iron oxide.36 To
circumvent subsequent carboxylic acid/iron oxide interaction, macromonomer 2,
as shown in Figure 3.1, was used for the synthesis of γ-Fe2O3-encapsulated
polymer nanoparticles (II).
Synthesis of γ-Fe2O3-encapsulated polymer nanoparticles (II). The
identical procedure for the synthesis of γ-Fe2O3-encapsulated polymer
nanoparticles (III) was applied to the synthesis of γ-Fe2O3-encapsulated polymer
nanoparticles (II), except that macromonomer 2 was used rather than
macromonomer 1.
Gel-phase NMR was used to analyze the resulting poly(ethylene glycol)coated magnetic polystyrene nanoparticles . For the measurement, MPNPs were
first dispersed in diluted HCl to remove the iron oxide core, and those
nanoparticles without iron oxide were then suspended in deuterated water. The
gel-phase proton NMR spectrum of the polymeric nanoparticles is compared with
that of macromonomer as shown in Figure 3.9. The PEG signal of nanoparticles at
3.65 ppm was seen to be strong and broad, while exhibiting no signals from the
polystyrene core.
Both SEM and TEM characterization were used to confirm the formation of
nanoparticles and their average size and size distributions. The SEM specimen
were prepared by depositing a small drop of the nanoparticle suspension onto a
SEM sample holder, and the TEM sample was prepared by depositing a small
drop of the same suspension onto a carbon-coated copper grid, followed by the

107

evaporation of the solvent. Figure 3.10 shows typical SEM and TEM images of
magnetic polymer nanoparticles. SEM imaging indicates that the nanoparticles
have a number average particle diameter of 130 nm (Figure 3.11). TEM shows
those iron oxide nanoparticles occur as clumps within the magnetic polymer
nanoparticles, with an average diameter of 55 nm (Figure 3.11). Figure 3.12
shows typical SEM and TEM images of the same magnetic polymer nanoparticles
from a different batch at a much lower concentration. As is clearly evident, these
nanoparticles were dispersed quite well.
The phase analysis was performed by X-ray powder diffraction. It can be seen
in Figure 3.4 that the spectrum of magnetic polymer nanoparticles is almost
identical to that of the oleic acid-coated magnetic nanoparticles. TGA studies
were also carried out for γ-Fe2O3-encapsulated polymer nanoparticles (II), also
shown in Figure 3.5. The TGA curve of the magnetic polymer nanoparticles (II)
shows a weight loss of approximately 88% caused by a temperature increase from
300 oC to 500 oC, which means that the iron oxide content in the magnetic
polymer nanoparticles is approximately 12%.
The magnetic properties of the synthesized magnetic polymer nanoparticles
are of high interest for use in further applications. Figure 3.6 shows a typical
hysteresis curve of magnetic polymer nanoparticles compared with that of oleic
acid-coated iron oxide nanoparticles. Obviously, the resulting magnetic polymer
nanoparticles are superparamagnetic with the saturation magnetization of value of
25.6 emu /g maghmite, which is lower than that of ferrofluid iron oxide (55.7
emu/g maghmite).
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Figure 3.9 1H NMR spectra of the macromonomer 2 (top) and
polymeric nanoparticles in D2O (Gel phase NMR, bottom).
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Figure 3.10 SEM (a) and TEM (b) of MPNPs (II).
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Figure 3.12 SEM (a) and TEM (b) images of MPNMs (II) at lower
concentration.
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Application of γ-Fe2O3–encapsulated polymeric nanoparticles in rapid
detection of Listeria monocytogenes. The results (Table 3.1, Figure 3.13) shown
here were kindly provided by Dr. Xiuping Jiang and Dr. Hua Yang in the
Department of Food Science and Human Nutrition at Clemson University.
Application of γ-Fe2O3–encapsulated polymeric nanoparticles as MRI
contrast agents. Results shown here were kindly provided by Dr. Jian-Ming Zhu
at Wake Forest University, School of Medicine (Figure 3.14).
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Figure 3.13A

Figure 3.13B

Figure 3.13C
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Figure 3.13A RT-PCR detection of L. monocytogenes, 106( ) and 107 ( )
CFU/0.5 mL, in artificially contaminated milk without immunomagnetic
nanoparticles. When DNA was directly extracted from the milk samples, there
was no RT-PCR amplification even at the concentration of 107 CFU/ml of L.
monocytogenes. (Courtesy of Dr. Xiuping Jiang and Dr. Hua Yang in the
Department of Food Science and Human Nutrition at Clemson University.)
Figure 3.13B RT-PCR detection of L. monocytogenes, 102 ( ), 103 ( ), 104
( ), 105 ( ), 106 ( ), 107 ( ) CFU/0.5 mL in artificially contaminated milk
after Dynabeads® -based IMS. For Dynabead®-based IMS in combination
with RT-PCR, only two L. monocytogenes concentrations at 106 and 107
CFU/ml were amplified. (Courtesy of Dr. Xiuping Jiang and Dr. Hua Yang in
the Department of Food Science and Human Nutrition at Clemson University.)
Figure 3.13C RT-PCR detection of L. monocytogenes, 102 ( ), 103 ( ), 104
( ), 105 ( ), 106 ( ), 107 ( ) CFU/0.5 mL in artificially contaminated milk
after IMPNPs-based IMS. when γ-Fe2O3–encapsulated polymeric
nanoparticles-based IMS was combined with RT-PCR, samples with
concentrations from 102 to 107 could be amplified and detected. (Courtesy of
Dr. Xiuping Jiang and Dr. Hua Yang in the Department of Food Science and
Human Nutrition at Clemson University.)
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Figure 3.14A In vitro MRI images show slice from 1.0 mL agarose gel
samples mixed with (a) Feridex IV (Ferumoxides injectable solution, Berlex
Laboratories, Montville, NJ); (b) γ-Fe2O3-encapsulated polymeric
nanoparticles; (c) PBS solutions. Images were acquired with a 7T MRI
scanner (Bruker Biospin, Germany). Image parameters: slice thickness = 0.4
mm, in-plane resolution = 120 um × 120 um, gradient echo sequence with
TE = 3.2 ms. For a and b, the net iron concentration was 0.0056 mg/ml.
MRI signal voids shown as dark spots on images a and b are from iron oxide
nanoparticles.
Figure 3.14B MRI image shows examples of γ-Fe2O3-encapsulated magnetic
polymer nanoparticles labeled stem cell imaging.
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3.4 Discussion
Synthesis of magnetic nanoparticles. In the literature, Fe3O4
nanoparticles are traditionally created using procedures found in the literature,
which involves grinding magnetite with long-chain hydrocarbon and a grinding
agent, e.g. oleic acid.20 Subsequent Fe3O4 nanoparticle production procedures,
commonly involved the use of NaOH, or NH3.H2O, as a base to coprecipitate
ferrous (Fe2+) and ferric (Fe3+) ions, in the medium of an aqueous solution.21
Although both processes result in the creation of tiny magnetite particles, the
coprecipitation process is obviously more feasible for application in the
production

of

more

homogeneous

magnetite

particles.

Therefore,

this

coprecipitation method was employed for use in the synthesis of the Fe3O4
nanoparticles (Scheme 3.3). As can be seen in Figure 3.2, the size distribution of
the Fe3O4 nanoparticles is considerably broad. Since Fe3O4 can be easily oxidized
into Fe2O3, it is necessary to remove the air from the system during the
preparation process.
Organic solution-phase decomposition of the iron precursor at high
temperatures has been widely used in the synthesis of iron oxide nanoparticles.
For example, decomposition of Fe(CO)5 followed by oxidation can lead to high
quality monodisperse γ-Fe2O3 nanoparticles (Scheme 3.4).31 In the work detailed
in this dissertation, this decomposition method was employed for the synthesis of
γ-Fe2O3 nanoparticles. As expected, highly crystalline and monodisperse γ-Fe2O3
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nanoparticles were obtained, which can be extensively verified by SEM, TEM,
TGA, X-ray powder diffraction, and SQUID.
Synthesis of iron oxide-encapsulated polymer nanoparticles. Iron oxide
nanoparticles were encapsulated in polystyrene nanoparticles by a miniemulsion
polymerization process, as shown in Scheme 3.5. Initially, a stable dispersion of
magnetic nanoparticles in styrene is required. Oleic acid for that purpose was
employed to make the particles hydrophobic, thusly preventing aggregation. Next,
the stable dispersion was miniemulsified in water by using surfactant and
ultrasound to form a stable miniemulsion. Since hexdecane was added to the
monomer phase as a hydrophobe to prevent Ostwald ripening, the miniemulsion
was already kinetically stable. Finally, the polymerization was begun by
increasing the temperature. The brown color did not change during the
polymerization, proving that the radical polymerization process did not
significantly interfere with morphology of the magnetic nanoparticles. X-ray
powder diffraction confirmed this observation, as shown in Figure 3.4.
Macromonomer was utilized as both the stabilizer and comonomer during the
polymerization process, which served as a surfactant to improve the miniemulsion
stability. Macromonomer also participitated in the polymerization process and the
formation of covalent bonds between styrene and macromonomer, thusly
increasing the stability of the resulting magnetic polymer nanoparticles.
The principle of miniemulsion polymerization indicates that iron oxide
nanoparticles should be encapsulated in polystyrene nanoparticles, which was
indeed confirmed by TEM, as shown in Figure 3.11. However, the distribution of
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maghemite nanoparticles within polymer nanoparticles was heterogenous, which
was presumably due to the interaction between the maghemite moieties and a
relative size- and content-specific destabilization of the miniemulsion droplets.25
Additionally,

in

the

miniemulsion

copolymerization

of

hydrophilic

macromonomers and hydrophobic monomers, the formation mechanism indicated
that hydrophilic chains were accumulated on the surfaces of particles, which was
confirmed by proton NMR spectroscopy, as shown in Figure 3.10. In such
conditions, no NMR signals were evident because that the polystyrene core was in
the solid state.37,38,39 Only the hydrophilic tethers were able to be detected.
Despite the absence of NMR signals, the NMR results were consistent with the
nanoparticle structure of a polystyrene core and flexible surface.
As shown in Figure 3.6, the reduction of saturation magnetization after
coating with polystyrene is probably the result of thick shell coatings on the
magnetic nanoparticles.40 However, it is found that the γ-Fe2O3-encapsulated
polymer nanoparticles (II) moved quite quickly under external magnetic field,
thusly enabling their complete separation from water in a very short time.
Therefore, the resulting magnetic force is strong enough for magnetic separation
in various biological applications.
To increase the maghemite content, an indirect process based on
miniemulsion polymerization has been recently introduced in the literature.21 In
details, oleic acid coated maghemite particles are dispersed in octane,
miniemulsified into water using sodium dodecyl sulfate (SDS) as a second
emulsifier and subsequently carefully heated to evaporate the octane to obtain an
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aqueous ferrofluid containing maghemite aggregates. For the encapsulation, a
mixture of the maghemite aggregate dispersion and a styrene miniemulsion is cosonicated, followed by a polymerization process. Up to 40 wt% maghemite could
be encapsulated by using this method.
Application of iron oxide-encapsulated polymer nanoparticles. The
synthesized magnetic polymer nanoparticles were used to improve the capture
efficiency of immunomagnetic separation of L. monocytogenes in comparison to
commercially available anti-Listeria Dynabeads®. Then RT-PCR was applied to
the cells captured by magnetic nanoparticles for a rapid and quantitative assay. As
shown in Figure 3.13, the γ-Fe2O3–encapsulated polymeric nanoparticles-based
IMS showed higher sensitivity and specificity of the subsequent PCR assays than
that of anti-Listeria Dynabeads®, which might due to the following reasons: (1)
Since γ-Fe2O3–encapsulated polymeric nanoparticles are much smaller than the
commercially available Dynabeads®, they have higher surface-to-volume ration to
contribute to the higher capture efficiency;41 (2) γ-Fe2O3 nanoparticles were
encapsulated in polystyrene, providing high stability with various conditions; (3)
Poly(ethyl glycol) is covalently attached on the surface of the magnetic polymer
nanoparticles, which can not only increase the biocompatibility of the
nanoparticles, but also provide enough active sites for the coupling of
biomolecules.
γ-Fe2O3–encapsulated polymeric nanoparticles were also used as contrast
agents for magnetic resonance imaging by our collaborator, Dr. Jian-Ming Zhu at
Wake Forest University, School of Medicine, which showed similar results with
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that of commercially available Ferumoxides injectable solution, the first liverspecific MRI enhancement agent.

3.5 Summary

In summary, a novel and effective protocol for the preparation of
biocompatible poly(ethylene glycol)-coated magnetic polymer nanoparticles by
the miniemulsion polymerization has been developed. Macromonomer served as
both comonomer and stabilizer during the miniemulsion process. TEM
observation reveals that these magnetic spheres are in the mean size of 130 nm
with iron oxide nanoparticles encapsulated inside. During the miniemulsion
polymerization, most of the magnetization compared to the oleic acid-coated
magnetic nanoparticles is still preserved. When compared with Dynabeads® in the
immunomagnetic separation, MPNPs-based PCR showed much higher sensitivity.
Furthermore, MPNPs could be used as contrast agents for magnetic resonance
imaging.
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CHAPTER 4
SOLUBLE NYLON-FUNCTIONALIZED CARBON NANOTUBES FROM
ANIONIC RING-OPENING POLYMERIZATION FROM NANOTUBE
SURFACE

4.1. Introduction
The preparation of polymeric nanocomposites filled with single-walled
carbon

nanotubes

(SWNTs)

generally

requires

the

nanotubes

being

homogeneously dispersed and compatible with the polymer matrix.1-3 An
effective approach for these requirements is to functionalize the nanotubes with
polymers that are identical or structurally similar to the matrix polymers.4 Among
the widely pursued functionalization strategies is the “grafting-from” method, in
which monomers or initiators are first attached to the nanotubes to serve as
starting points for propagation.5-9 The grafting-from strategy is generally similar
to in situ polymerization,10 but in a more controlled fashion. For example, the
nanotube-bound radical initiators were used in the atom transfer radical
polymerization to yield poly(methyl methacrylate)-, poly(n-butyl methacrylate)-,
or poly(t-butyl acrylate)-functionalized carbon nanotubes.5
Nylon is an important commodity polymer with a wide variety of
applications, and naturally, there has been much interest in nanocomposites of
nylon with carbon nanotubes.11-18 For the investigation of these materials, the
preparation of nylon-functionalized carbon nanotubes is highly relevant and

beneficial. In a typical synthesis of nylon 6, ε-caprolactam is used as monomer in
the efficient anhydrous polymerization with a base (anionic) as initiator.19 In
addition, the secondary amine in ε-caprolactam may be used to form an amide
linkage with the defect-derived carboxylic acid moiety on the carbon nanotube
surface. We report here that the covalent attachment of ε-caprolactam molecules
to SWNTs could be the first step in a two-step grafting-from process of
functionalizing the nanotubes with nylon 6. The second step was the anionic ringopening polymerization of the nanotube-bound ε-caprolactam species with the
same monomers in bulk (Scheme 4.1). The same method was also employed for
the functionalization of multi-walled carbon nanotubes (MWNTs) and vaporgrown carbon nanofibers (VGCFs) with nylon 6. Polymer/carbon nanocomposites
from these resulting nylon-functionalized carbon nanotubes and carbon nanofibers
were characterized by NMR, TEM, SEM, TGA, and Raman spectra (Chapter 5).
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Scheme 4.1. Synthesis of nylon 6-functionalized single-walled carbon
nanotubes (Nylon-SWNT).
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4.2. Experimental Section

Materials. ε-Caprolactam was purchased from Aldrich. Thionyl chloride
and sodium were obtained from Alfa Aesar. Deuterated solvents for NMR
measurements were supplied by Cambridge Isotope Laboratories.
The sample of SWNTs (arc-discharge method) was supplied by Carbon
Solutions, Inc. It was purified by using a combination of thermal oxidation and
oxidative acid treatment. In a typical experiment, a nanotube sample (1 g) was
thermally oxidized in air in a furnace at 300 ºC for 30 min. After the thermal
treatment, the remaining sample was added to an aqueous HNO3 solution (2.6 M),
and the mixture was refluxed for 24 h. Upon centrifuging at 1,000 g to discard the
supernatant, the remaining solids were washed with deionized water until neutral
pH and then dried under vacuum.
Measurements. NMR measurements were performed on a JEOL Eclipse
+500 NMR spectrometer and a Bruker Avance 500 spectrometer that is equipped
with a high-resolution magic-angle-spinning (HR-MAS) probe designed
specifically for gel-phase NMR. Optical absorption spectra were recorded on a
Shimadzu UV3100 spectrophotometer. Raman spectra were obtained on a
Renishaw Raman spectrometer equipped with a 50 mW diode laser source for 785
nm excitation and a CCD detector. Thermogravimetric analysis (TGA) was
carried out on a Mettler-Toledo TGA/SDTA851e system. Scanning electron
microscopy (SEM) images were obtained on a Hitachi S4700 field-emission SEM
system. Atomic force microscopy (AFM) analysis was conducted on a Molecular
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Imaging PicoPlus system equipped with a multipurpose scanner. The height
profile analyses were assisted by using the SPIP software distributed by Image
Metrology.
Caprolactam-SWNT. A purified SWNT sample (50 mg) was mixed with
thionyl chloride (10 mL), and the mixture was stirred and refluxed (70 EC) for 24
h. Upon removal of excess thionyl chloride under vacuum, ε-caprolactam (5 g, 44
mmol) was added. The mixture was stirred at 110 EC for 24 h, and then cooled to
room temperature. Chloroform (20 mL) was added to the mixture, and the
resulting suspension was filtered (0.22 :m PVDF membrane). The solid sample
from the filtration was extracted with chloroform for 6 h in a Soxhlet extractor to
remove any residual ε-caprolactam. Upon drying in vacuum at room temperature,
the ε-caprolactam-functionalized SWNTs (caprolactam-SWNT) were obtained as
a dark-colored powdery sample.
Nylon-SWNT. A caprolactam-SWNT sample (50 mg) was mixed with εcaprolactam (10 g, 88 mmol), and sodium (40 mg, 1.7 mmol) was added to the
mixture as initiator for the polymerization reaction at 140 EC under nitrogen
protection for 24 h (Scheme 1). The reaction mixture was dissolved in formic acid
(10 mL), precipitated into water (50 mL), and filtered (0.22 :m PVDF
membrane). The resulting solid sample was washed successively (25 mL each)
with formic acid, water, and formic acid again to remove sodium salts and those
polymers not attached to the nanotubes (until no such polymers found in the
filtrate). The cleaned sample was dispersed in formic acid (10 mL), followed by
centrifuging (3,000 g) to retain the dark-colored supernatant. The solvent formic
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acid was removed on a rotatory evaporator to yield nylon 6-functionalized
SWNTs (Nylon-SWNT) as black solids.

4.3. Results and Discussion

The functionalization of SWNTs with ε-caprolactam was the first step in
the grafting-from process. The caprolactam-SWNT sample was generally
insoluble in common organic solvents. Nevertheless, its dispersion in formic acid
was used for 1H NMR measurement, yielding rather broad resonances (Figure
4.1). The broadening was probably due in part to the heterogeneous nature of the
dispersion, in addition to the high molecular weight and low mobility of carbon
nanotubes. Better resolved proton signals were obtained from the same dispersion
by using a high-resolution magic-angle-spinning (HR-MAS) probe designed
specifically for gel-phase NMR (Figure 4.1). The resonances of the nanotubeattached ε-caprolactam were systematically shifted upfield from those of the
starting ε-caprolactam, especially for the methylene protons near the expected
amide linkage (3.24 and 2.50 ppm vs 3.03 and 2.25 ppm, Figure 4.1). In the
literature,20,21 similar upfield-shifts have been attributed to effects associated with
the large aromatic ring current in nanotubes, which are more pronounced when
the protons are closer to the nanotube surface. The NMR results are consistent
with the covalent attachment of ε-caprolactam molecules to SWNTs.
The FT-IR spectrum of the caprolactam-SWNT sample exhibited
absorptions at 2,930 cm-1 and 2,860 cm-1, corresponding to the stretching modes
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of alkyl C-H in ε-caprolactam. As compared in Figure 4.2, the Raman spectrum
(785 nm excitation) of the caprolactam-SWNT sample is similar to that of
purified SWNTs, showing typical radial breathing mode (170 cm-1), D-band
(1,310 cm-1), tangential G-band (1,580 cm-1), and D*-band (2,660 cm-1) features.
The absence of luminescence interference reflects the expected low functional
group content in the caprolactam-SWNT sample, also consistent with the poor
solubility of the sample. In thermogravimetric analysis (TGA) of the sample
under inert atmosphere, the covalently-attached ε-caprolactam on the nanotube
surface could be selectively removed (or “thermal defunctionalization”),1,4,6-8
which allowed an estimate of the ε-caprolactam content in the sample. The
content was indeed low, ~7% (wt/wt), as expected. It corresponds to on average
one ε-caprolactam for every 125 nanotube carbons.
The second step in the grafting-from process was the sodium-initiated
anionic ring-opening polymerization to obtain nylon 6-functionalized SWNTs.
The final Nylon-SWNT sample contained more than 70% of the starting SWNTs.
The sample was soluble in some organic solvents, such as formic acid and mcresol, resulting in dark-colored but optically transparent solutions.
The 1H NMR spectrum of Nylon-SWNT in deuterated formic acid is
compared with that of commercially available nylon 6 (Acros, Mn ~ 10,000) in
Figure 4.3. The chemical shifts in the two spectra are generally similar, but the
resonances of the nanotube-bound nylon moieties are obviously broader. Unlike
in the dispersion of caprolactam-SWNT discussed above, the broadening here is
probably due entirely to the nylon species being associated with the nanotubes
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Figure 4.1 1H NMR spectra of ε-caprolactam-functionalized singlewalled carbon nanotubes (caprolactam-SWNT) dispersed in deuterated
formic acid ((a): measured in solution probe, and (b): in high-resolution
magic angle spinning probe) are compared with that of ε-caprolactam
(c).
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Figure 4.2 Raman spectra (785 nm excitation) of the purified singlewalled carbon nanotube (SWNT) sample (top) and caprolactamSWNT (bottom).
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Figure 4.3 A comparison of 1H NMR spectra of nylon 6-functionalized
SWNTs (Nylon-SWNT, a) and nylon 6 (b) in deuterated formic acid solutions.
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(high molecular weight and low mobility) because the Nylon-SWNT solution is
homogeneous.
The nylon functionalities on the nanotube surface could also be selectively
removed in TGA under inert atmosphere (thermally defunctionalized), similarly
allowing an estimate of the nanotube content. According to the amount of residue
at 500 EC, the Nylon-SWNT sample contained about 40% (wt/wt) of nanotubes.22
The optical absorption spectrum of Nylon-SWNT is shown in Figure 4.4.
The broad S11 and S22 bands at 1,870 nm and 1,050 nm, respectively, are
characteristic of the electronic transitions associated with the van Hove singularity
pairs in semiconducting SWNTs.23 The spectral similarity to that of purified
SWNTs suggests that neither the polymerization reaction nor the presence of
nylon functionalities on the nanotube surface change in any substantial fashion
the electronic transitions. Apparently, the nanotube electronic structures are
largely preserved in the nylon-functionalized SWNTs, as also found in a number
of other functionalizations that target the nanotube surface defect-derived
carboxylic acids.4,7
The Raman characterization of Nylon-SWNT was hindered by
overwhelming luminescence interference, quite different from the same
characterization of the precursor caprolactam-SWNT (Figure 4.5). As reported
recently,24 the substantial difference in the extent of luminescence interference in
Raman measurements is an indication on how well the nanotubes are dispersed
and functionalized. In the Nylon-SWNT sample, soluble in selected solvents to
form transparent solutions, the nanotubes were well-dispersed and their surface
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Figure 4.4 Absorption spectra of nylon 6-functionalized single-walled
carbon nanotubes (Nylon-SWNT, top) and the purified SWNT sample
(bottom) on glass substrate.
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Figure 4.5 Raman spectra (785 nm excitation) of the nylon 6functionalized SWNTs (Nylon-SWNT) before (top) and after (bottom)
thermal defunctionalization (800 oC, N2).
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defects were likely passivated as a result of the effective functionalization, thus
corresponding to stronger nanotube defect-derived luminescence.1,24 The thermal
defunctionalization obviously “un-dispersed” the nanotubes, suppressing or
completely eliminating the luminescence interference. As compared in Figure 4.5,
the Raman spectrum of the thermally defunctionalized Nylon-SWNT sample
again exhibits features similar to those of purified SWNTs.
A direct SEM imaging of the nylon-functionalized SWNTs was somewhat
difficult because of a significant amount of soft (nylon polymer) materials in the
specimen (Figure 4.6). However, the removal of nylon via thermal
defunctionalization obviously made the SEM analysis more straightforward, with
the resulting image showing abundant SWNTs (Figure 4.6). AFM is applicable to
the direct analysis of functionalized carbon nanotubes. For Nylon-SWNT, the
specimen for AFM analysis was prepared by spraying a dilute formic acid
solution of the sample onto a mica substrate. During the spraying, the substrate
was kept at 120 EC to facilitate rapid solvent evaporation in an effort to preserve
the original nanotube dispersion in the solution. A representative AFM
topographic image from the analysis of such a specimen is shown in Figure 4.7.
There are apparently abundant nanotubes of different lengths (hundreds of
nanometers), mostly well-dispersed to the individual nanotube level according to
the height analysis (Figure 4.7). It seems that the AFM specimen was unusually
well-prepared (with a significant population of well-dispersed individual
SWNTs), which probably benefitted from the use of the highly polar solvent
formic acid. The solvent effect might be that the nanotube surface is charged, as
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in the superacid dispersion25 or electrolyte-assisted dispersion of carbon
nanotubes,26 thus resulting in more efficient exfoliation of the nanotube bundles
(or preventing the functionalized SWNTs from aggregating).
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400 nm

400 nm

Figure 4.6 Scanning electron microscopy (SEM) images of the
nylon 6-functionalized single-walled carbon nanotubes (NylonSWNT) sample before (top) and after (bottom) thermal
defunctionalization (800 oC, N2).
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Figure 4.7 Atomic force microscopy (AFM) topography image (top)
and height analysis (bottom) of a nylon 6-functionalized single-walled
carbon nanotubes (Nylon-SWNT) specimen (prepared by spraying the
sample solution onto a heated mica substrate).
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4.4. Summary
In summary, the functionalization of SWNTs with nylon 6 was accomplished by
using the grafting-from strategy in a two-step process, where the covalent
attachment of ε-caprolactam molecules to nanotubes was followed by the anionic
ring-opening polymerization of these bound ε-caprolactam species with the same
monomers in bulk. The resulting sample was characterized systematically, and the
results were supportive of the expected covalent functionalization of SWNTs by
nylon 6. This is a relatively convenient but still reasonably controllable method to
chemically modify carbon nanotubes with a commodity polymer of extremely
wide uses. The solubility of the functionalized nanotube sample in some organic
solvents may prove valuable to the homogeneous dispersion of SWNTs in nylon
for high-quality nanocomposite materials.

References.

1.

Sun, Y.-P.; Fu, K.; Lin, Y.; Huang, W. Acc. Chem. Res. 2002, 35, 10961104.

2.

Grady, B. P.; Pompeo, F.; Shambaugh, R. L.; Resasco, D. E. J. Phys.
Chem. B 2002, 106, 5852-5858.

3.

Mitchell, C. A.; Bahr, J. L.; Arepalli, S.; Tour, J. M.; Krishnamoorti, R.
Macromolecules 2002, 35, 8825-8830.

4.

(a) Hill, D. E.; Lin, Y.; Rao, A. M.; Allard, L. F.; Sun, Y.-P.
Macromolecules 2003, 35, 9466-9471. (b) Lin, Y.; Zhou, B.; Fernando,
K. A. S.; Liu, P.; Allard, L. F.; Sun, Y.-P. Macromolecules 2003, 36,
7199-7204. (c) Qu, L.; Lin, Y.; Hill, D. E.; Zhou, B.; Wang, W.; Sun,
X.; Kitaygorodskiy, A.; Suarez, M.; Connell, J. W.; Allard, L. F.; Sun, Y.P. Macromolecules 2004, 37, 6055-6060.
144

5.

(a) Yao, Z.; Braidy, N.; Botton, G. A.; Adronov, A. J. Am. Chem. Soc.
2003, 125, 16015-16024. (b) Kong, H.; Gao, C.; Yan, D. J. Am. Chem.
Soc. 2004, 126, 412-413. (c) Qin, S.; Qin, D.; Ford, W. T.; Resasco, D.
E.; Herrera, J. E. J. Am. Chem. Soc. 2004, 126, 170-176. (d) Baskaran,
D.; Mays, J. W.; Bratcher, M. S. Angew. Chem. Int. Ed. 2004, 43, 21382142.

6.

Liu, Y.; Adronov, A. Macromolecules 2004, 37, 4755-4760.

7.

(a) Kong, H.; Li, W.; Gao, C.; Yan, D.; Jin, Y.; Walton, D. R. M.; Kroto,
H. W. Macromolecules 2004, 37, 6683-6686. (b) Xu, Y.; Gao, C.; Kong,
H.; Yan, D.; Jin, Y. Z.; Watts, P. C. P. Macromolecules 2004, 37, 88468853. (c) Gao, C.; Jin, Y. Z.; Kong, H.; Whitby, R. L. D.; Acquah, S. F.
A.; Chen, G. Y.; Qian, H.; Hartschuh, A.; Silva, S. R. P.; Henley, S.;
Fearon, P.; Kroto, H. W.; Walton, D. R. M. J. Phys. Chem. B 2005,
109, 11925-11932.

8.

Qin, S.; Qin, D.; Ford, W. T.; Resasco, D. E.; Herrera, J. E.
Macromolecules 2004, 37, 752-757.

9.

(a) Hong, C.-Y.; You, Y.-Z.; Wu, D.; Liu, Y.; Pan, C.-Y. Macromolecules
2005, 38, 2606-2611. (b) Hong, C.-Y.; You, Y.-Z.; Pan, C.-Y. Chem.
Mater. 2005, 17, 2247-2254.

10.

Tang, B. Z.; Xu, H. Macromolecules 1999, 32, 2569-2576.

11.

Stevens, J. L.; Huang, A. Y.; Peng, H.; Chiang, I. W.; Khabashesku, V.
N.; Margrave, J. L. Nano Lett. 2003, 3, 331-.336.

12.

Xia, H.; Wang, Q.; Qiu, G. Chem. Mater. 2003, 15, 3879-3886.

13.

Zhang, W. D.; Shen, L.; Phang, I. Y.; Liu, T. Macromolecules 2004, 37,
256-259.

14.

Liu, T.; Phang, I. Y.; Shen, L.; Chow, S. Y.; Zhang, W.-D.
Macromolecules 2004, 37, 7214-7222.

15.

Sandler, J. K. W.; Pegel, S.; Cadek, M.; Gojny, F.; van Es, M.; Lohmar, J.;
Blau, W. J.; Schulte, K.; Windle, A. H.; Shaffer, M. S. P. Polymer 2004,
45, 2001-2015.

16.

Li, C. Y.; Li, L.; Cai, W.; Kodjie, S. L.; Tenneti, K. K. Adv. Mater. 2005,
17, 1198-1202.

145

17.

Endo, M.; Koyama, S.; Matsuda, Y.; Hayashi, T.; Kim, Y.-A. Nano Lett.
2005, 5, 101-105.

18.

Gao, J.; Itkis, M. E.; Yu, A.; Bekyarova, E.; Zhao, B.; Haddon, R. C. J.
Am. Chem. Soc. 2005, 127, 3847-3854.

19.

Aharoni, S. M. n-Nylons: Their Sythesis, Structure and Properties; John
Wiley & Sons: Chichester, 1997.

20.

(a) Chen, J.; Liu, H.; Weimer, W. A.; Halls, M. D.; Waldeck, D. H.;
Walker, G. C. J. Am. Chem. Soc. 2002, 124, 9034-9035. (b) Holzinger,
M.; Abraham, J.; Whelan, P.; Graupner, R.; Ley, L.; Hennrich, F.; Kappes,
M.; Hirsch, A. J. Am. Chem. Soc. 2003, 125, 8566-8580. (c) Ruther, M.
G.; Frehill, F.; O’Brien, J. E.; Minett, A. I.; Blau, W. J.; Vos, J. G.; in het
Panhuis, M. J. Phys. Chem. B 2004, 108, 9665-9668.

21.

According to the software ACD/HNMR Predictor for predicting NMR
chemical shifts, amidation should result in downfield shifts of as much as
0.5 - 1 ppm for the adjacent caprolactam methylene protons. Therefore,
the observed upfield shifts must be due to strong influence of the nanotube
aromatic system, which overcomes the opposite effect from the amidation.

22.

Based on the population of ε-caprolactam in the caprolactam-SWNT
sample, the composition in Nylon-SWNT corresponds to about 20
repeating units in each nanotube-attached nylon-6 chain (molecular weight
~ 2200).

23.

Niyogi, S.; Hamon, M. A.; Hu, H.; Zhao, B.; Bhowmik, P.; Sen, R.; Itkis,
M. E.; Haddon, R. C. Acc. Chem. Res. 2002, 35, 1105-1113.

24.

Lin, Y.; Zhou, B.; Martin, R. B.; Henbest, K. B.; Harruff, B. A.; Riggs, J.
E.; Guo, Z.-X.; Allard, L. F.; Sun, Y.-P. J. Phys. Chem. B 2005, 109,
14779-14782.

25.

Davis, V. A.; Ericson, L. M.; Parra-Vasquez, A. N. G.; Fan, H.; Wang, Y.;
Prieto, V.; Longoria, J. A.; Ramesh, S.; Saini, R. K.; Kittrell, C.; Billups,
W. E.; Adams, W. W.; Hauge, R. H.; Smalley, R. E.; Pasquali, M.
Macromolecules 2004, 37, 154-160.

26.

Penicaud, A.; Poulin, P.; Derre, A.; Anglaret, E.; Petit, P. J. Am. Chem.
Soc. 2005, 127, 8-9.

146

CHAPTER 5
FUNCTIONALIZATION OF CARBON NANOTUBES AND NANOFIBERS
FOR IMPROVED DISPERSION IN POLYMERIC NANOCOMPOSITES

5.1 Introduction
Recently, there has been intense research concerning the fabrication and
application of polymer-carbon nanostructure composite materials.1-7 The carbon
nanostructured materials especially carbon nanotubes (both single-walled
(SWNT) and multi-walled (MWNT) carbon nanotubes) and vapor grown carbon
nanofibers (VGCFs) have shown exceptional physical, mechanical, electrical,
thermal, and optical properties.7-9 They are considered to be the ultimate
reinforcing systems for polymer matrices. Significant advances have been
reported in the processing of carbon nanostructured/polymer composite films6-7,1014

and fibers.4a,6,15-17 These studies agreed that the key factors to realize high

quality nanoreinforcement of the composites are (1) a good dispersion of the filler
in polymer matrix ; (2) a strong interfacial bonding between the filler and
polymer; and (3) good alignment of the filler in polymer matrix. Previous
methodologies explored for the dispersion of these carbon nanostructures were
mainly by their sonication in polymer solution,16,18,19 in-situ polymerization,20-22
and surfactant-assisted processing.23-25 Recently, chemical functionalization of
these carbon nanostructures has emerged as an effective method for promoting
their dispersion into polymeric matrices and in optimizing the performance of the
nanocomposites.3,26-31 Several functionalization (covalent and non-covalent)
approaches on the tube ends and side walls of MWNTs and VGCFs with organic

species like long chain alcohols and amines, dendrimers and polymers have been
reported.3,26-31

The

functionalization

has

been

accomplished

by

either

modification of surface-bound carboxylic acid groups on the nanotubes or by
direct addition of reagents to the sidewalls of nanotubes. The most pursued
strategy for the covalent grafting of polymers to nanotubes has been the process
of “grafting from”, in which monomers or initiators are initially attached onto the
nanotube surface, followed by the in-situ polymerization of the monomers.32-37
For example, carbon nanotubes were functionalized with poly(methyl
methacrylate),

poly(n-butyl

methacrylate),

poly(tert-butyl

acrylate),

and

polystyrene by using the nanotube-bound radical initiators in the atom transfer
radical polymerization.32-37 We have recently used similar strategy to
functionalize SWNTs with nylon-6 via a covalent attachment of ε-caprolactam
molecules to nanotubes followed by the anionic ring-opening polymerization of
these bound ε-caprolactam species with the same monomers in bulk.38
The chemical functionalization of CNTs has also been employed for the
fabrication of high-quality polymeric carbon nanocomposites to improve both the
degree of CNT dispersion in a polymer matrix and the interfacial bonding
strength.39-40 The most appropriate method for this fabrication has been the use of
polymers that are structurally and property-wise identical or close to the matrix
polymer. This method ensures that the dispersed carbon nanotubes are compatible
with the polymer matrix, thusly avoiding unwanted “impurities” associated with
the dispersion agents and any potential microscopic phase separation in the
nanocomposites.39-40 The most commonly used techniques for the fabrication of
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polymeric carbon nanocomposite materials relied on solution casting,20,41-43 melt
spinning,44 and extrusion processing.15a,21,24 Recently, these composite materials
were also processed into fiber yarns by using electrospinning technique and
showed strong elongation, orientation, and distribution of nanotubes in the
nanofibers.4a,15-17,45 This method is a nanofiber assembly technique that utilizes an
external electrostatic field to generate small fibers with high surface areas and
diameters on the nanometer scale. Achieving macroscopic orientation of MWNTs
in the polymer matrix of nanofibers during electrospinning has been considered a
necessary step towards the development of many meaningful technological
applications.15,45 For instance, locally oriented nanotubes embedded in nanofibers
electrospun from poly(ethylene oxide)- (PEO)/SDS/MWNT and PEO/Gum
Arabic/MWNT were observed using transmission electron microscopy, in which
SDS and Gum Arabic were used as binding agents in aqueous dispersions.45a
Another approach used in the production of highly aligned MWNTs embedded
within electrospun PAN nanofibers was achieved by collecting the nanofibers
onto a winder with a surface velocities larger than the velocities of electrospun
nanofibers. Exciting breakthroughs were achieved from this experimentation,
demonstrating the potential of these carbon nanostructures in enhancing
mechanical strength, electrical conductivity, and thermal conductivity.
As a new class of carbon nanofibers, vapor grown carbon fiber (VGCF)
differs from carbon nanotubes in both its production method and lower cost.
VGCFs have a high aspect ratio and nano-sized outer diameter of 50-200 nm, a
hollow core of 30-90 nm.46,47 Because of its excellent thermal and electrical
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conductivity, and good mechanical behavior, VGCF is of great interest and
mostly used in the form of composites where the polymer required as an aspect of
the matrices. For example, VGCF is usually used as reinforcement, adsorbent, and
conductive filler. However, because of the very low surface free energy, nanosize,
and low bulk density, the ability to disperse, stabilize and make VGCF compatible
to polymer matrices still remains a challenge.
Although methodologies for the functionalization and dispersion of carbon
nanotubes have been well developed and thoroughly reported in the literature,
very little research has been reported on the dispersion and functionalization of
VGCF.

31,48,49

Since VGCF has a similar surface structure to that of carbon

nanotubes, the methodologies for the functionalization and dispersion of carbon
nanotubes may be applied to the functionalization and dispersion of VGCFs. In
this present dissertation, the functionalization of VGCFs with PPEI-EI through
the amidation reaction has been reported, along with an extension of the graftingfrom strategy for the functionalization of both MWNTs and VGCFs with nylon-6.
The functionalized samples were found to share solubility and compatibility with
nylon-6 polymer in formic acid, which allowed for the formation of high-quality
nylon-MWNTs

and

VGCFs

composites nanoscale fiber mats through

electrospinning. Results from characterizations of these solubilized carbon
nanostructures and the nanocomposite fibers are presented and discussed.
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5.2 Experimental Section

Materials. ε-Caprolactam was purchased from Aldrich. PVA (MW ~ 70
000-100 000, 99% hydrolyzed), thionyl chloride and sodium were obtained from
Alfa

Aesar.

N,N'-Dicyclohexylcarbodiimide

(dimethylamino)pyridine

(DMAP,

Poly(propionylethylenimine)

(PPEI,

99%)
MW

(DCC,

were
of

99%)

obtained

50,000

and

from

and

4-

Acros.

200,000),

1-

hydroxybenzotriazole (HOBT, containing less than 5% H2O) and trifluoroacetic
acid (TFA, 99%) were from Sigma-Aldrich. Dimethyl sulfoxide (DMSO, 99.5%)
and N,N’-dimethylformamide (DMF, 99%) were purchased from Burdick &
Jackson and Acros, respectively, and dried over molecular sieves before use.
Deuterated solvents for NMR measurements were supplied by Cambridge Isotope
Laboratories. Dialysis membranes were supplied by Spectrum Laboratories.
MWNT samples were supplied by Nanostructured and Amorphous Materials Inc.
and purified via an oxidative acid treatment.3 In a typical purification, a MWNT
sample (1 g) was suspended in a 50 mL of 60% HNO3 aqueous solution and
sonicated in a bath (40 kHz) for 30 min. The mixture was then stirred for 24 h
under reflux. After cooling to room temperature, it was diluted with 100 mL of
deionized water and then vacuum-filtered through a 2.0 µm PTFE membrane. The
solid was washed with deionized water until neutral pH and then dried under
vacuum to give 0.7 g (70%) of carboxylic acid-functionalized MWNT. Figure 1
shows a typical SEM image of purified MWNTs.
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a

1 µm

b

1 µm

Figure 5.1 SEM image of purified VGCFs (a) and MWNTs (b).
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Vapor grown carbon nanofibers (VGCF, PR-19-PS) were obtained from
Applied Science Inc., Cedarville, OH. The diameter and length of the VGCFs
were in the range of 60-200 nm and 30-100 µm, respectively. Surface oxidization
of VGCFs was performed by heating VGCFs in concentrated nitric acid at 140 °C
for 4 h. The product was filtered and washed with deionized water until neutral.
The surface oxidized carbon nanofibers were vacuum-dried at room temperature
for 2 days to remove residual water. Figure 5.1 shows a typical SEM image of
purified VGCFs, with an average length of ~ 3 µm.
PPEI-EI

Copolymer.

Poly(propionylethylenimine-coethylenimine)

(PPEI-EI) random copolymers were prepared via partially hydrolyzing PPEI
polymers.50 In a typical reaction, a PPEI sample (MW - 200,000, 1 g) was
dissolved in methanol (5 mL). After water (50 mL) was added, methanol was
evaporated via heating. Aqueous HCl (1 M, 2 mL) was added to the solution,
followed by refluxing for 24 h. The reaction mixture was cooled to ambient and
was then neutralized with aqueous NaOH to a pH of ~10. Upon the removal of
water, the product was extracted with chloroform and precipitated into hexane,
followed by drying under vacuum to yield the PPEI-EI copolymer as a white
solid. 1H NMR (500 MHz, CDCl3): δ 3.6-3.2 (2*NCH2), 2.9-2.6 (2*NHCH2), 2.52.2 (COCH2CH3), 2.1-1.8 (NHCH2), 1.2- 1.0 (COCH2CH3) ppm; 13C NMR (125
MHz, CDCl3): δ 174 (C=O), 48.5 (2xNCH2), 44 (2xNHCH2), 26 (COCH2CH3),
9.3 (COCH2CH3) ppm. The EI mole fraction in the random copolymer xNH was
estimated in terms of the 1H NMR signal integrations
xNH = I2.8/(I2.8 + I3.4)
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The mole fraction xNH could be controlled by varying the hydrolysis
reaction time. For the PPEI-EI copolymers used in this study, the xNH value was
generally ~20%.
PPEI-EI-VGCF. VGCFs were functionalized with PPEI-EI through two
different methods.50 The first is the acylation-amidation reaction method, using
thionyl chloride as an acylation agent for subsequent amidation; The second is the
direct heating method. In a typical direct heating reaction, a VGCF sample (25
mg) was heated with PPEI-EI (MW ~ 200 000, 250 mg) at 160-180 oC under
nitrogen protection for 12 h. After the reaction mixture was allowed to return to
the ambient temperature, it was repeatedly extracted with chloroform. The
functionalized carbon nanofibers in the dark chloroform solution were
precipitated into hexane. The sample was re-dissolved in de-ionized water for
dialysis (dialysis tubing cutoff molecular weight ~ 1 000 000) against freshwater
for 3 days. Further purification included the precipitation from chloroform
solution into hexane, followed by the solvent removal and drying under vacuum.
The PPEI-EI-functionalized VGCFs were obtained as dark solids. 1H NMR (500
MHz, CDCl3) δ 4.6-3.1, 2.9-2.7, 2.6-1.9, 1.5-0.5 ppm.
In a typical acylation-amidation reaction, a purified VGCF sample (25
mg) was refluxed with SOCl2 (4 mL) for 24 h to convert the carboxylicacids into
acyl chlorides. Upon removing the excessive SOCl2 under vacuum, PPEI-EI (MW
~ 200 000, 250 mg) was added to the acylated VGCFs and the mixture was kept
at 160-180 °C under nitrogen for 24 h. The extraction and purification procedures
were the same as those described above.
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Caprolactam-MWNT. A purified MWNT sample (50 mg) was mixed
with thionyl chloride (10 mL), and the mixture was stirred and refluxed (70 °C)
for 24 h. Upon removal of excess thionyl chloride under vacuum, ε-caprolactam
(5 g, 44 mmol) was added. The mixture was stirred at 110 °C for 24 h and then
cooled to room temperature. Chloroform (20 mL) was added to the mixture, and
the resulting suspension was filtered (0.22 µm PVDF membrane). Upon drying in
a vacuum at room temperature, the caprolactam-functionalized MWNTs
(caprolactam-MWNT) were obtained as a dark-colored powdery sample.
Nylon-MWNT. A caprolactam-MWNT sample (50 mg) was mixed with
ε-caprolactam (10 g, 88 mmol). Sodium (40 mg, 1.7 mmol) was then added to the
mixture as an initiator for the polymerization reaction at 140 °C, under nitrogen
protection, for 24 h (Scheme 5.1). The reaction mixture was dissolved in formic
acid (10 mL), precipitated into water (50 mL) and filtered (0.22 µm PVDF
membrane). The resulting solid sample was washed successively (25 mL each)
with formic acid, water, and formic acid again to remove sodium salts and those
polymers not attached to the nanotubes (until no such polymers remained in the
filtrate). The solvent formic acid was removed on a rotatory evaporator to yield
nylon-6-functionalized MWNTs (nylon-MWNT) as black solids.
Nylon-VGCF.

The

reaction

of

caprolactam

and

then

nylon

functionalization with VGCFs (nylon-VGCF) was carried out by the same
procedure with MWNTs.
Measurements. NMR measurements were performed on a JEOL Eclipse
+500 NMR spectrometer and a Bruker Avance 500 spectrometer equipped with a
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high-resolution magic-angle-spinning (HR-MAS) probe designed specifically for
gel-phase NMR. Optical absorption spectra were recorded on a Shimadzu
UV3100 spectrophotometer. Raman spectra were obtained on a Renishaw Raman
spectrometer equipped with a 50 mW diode laser source for 785 nm excitation
and a CCD detector. Thermogravimetric analysis (TGA) was carried out on a
Mettler-Toledo TGA/SDTA851e system. Scanning electron microscopy (SEM)
images were obtained on a Hitachi S4700 field-emission SEM system.
Transmission electron microscopy (TEM) analyses were conducted on Hitachi
HF-2000 TEM and Hitachi HD-2000 TEM/STEM systems, both with the digital
imaging capability. Atomic force microscopy (AFM) analysis was conducted on a
Molecular Imaging PicoPlus system equipped with a multipurpose scanner.
Electrospinning. The nylon-MWNT or nylon-VGCF was mixed with
commercial nylon in formic acid in order to achieve viscoelastic and spinnable
solution. The mixing ratio was controlled so that the nanotube/nanofiber content
in the final fiber composite was 15 wt%. The nylon served also as the polymeric
matrix of the electrospun nanofibers in which the nanotubes/VGCFs were
embedded after solvent evaporation. The dispersions were directly used in the
electrospinning process. The required volume (10 mL) of the solution was loaded
into a syringe fitted to a syringe pump. The positive terminal of a Spellmann high
voltage DC power supply was connected to the metallic needle of the syringe. A
grounded stainless steel sheet placed 3 cm from the tip of the needle was used as
the target to deposit the membranes, and the syringe pump was set to deliver the
solution at a rate of 4 mL/h. When the first drop appeared at the tip of the needle,
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the high voltage (15 kV) was applied. Electrospinning was carried out at room
temperature in air for 1 h, and the samples were peeled from the target as freestanding membranes.

5.3 Results

PPEI-EI-VGCFs. The functionalization of MWNTs with amino
polymers, such as PPEI-EI, by reaction with acrylic acid groups on the surface
has been reported in the literature.50 Here, the same methods were applied to
functionalize purified VGCFs with PPEI-EI through both the acylation-amidation
(“SOCl2 method”) and the direct heating (“heating method”). PPEI-EI-VGCF
samples are soluble in many common organic solvents such as chloroform and
DMSO and also in water, forming dark-colored solutions. Since PPEI-EI is
colorless, the dark color serves as a visual indication of VGCFs in the solution.
The solubility of PPEI-EI-VGCFs enabled high-resolution NMR
characterization in solution. The 1H NMR spectra of the PPEI-EI-VGCFs in
deuterated chloroform were compared with that of the parent PPEI-EI in Figure
5.2. Upon the attachment of PPEI-EI to nanofibers, the spectra changed greatly in
both character and composition. The signal broadening for PPEI-EI-VGCFs may
be attributed to the attachment of the PPEI-EI to nanofibers as species of high
molecular weight and low mobility.51 Another observed change was the absence
of proton signals at ~2 ppm and 2.8 ppm from ethylenimine EI units. These
signals could be either broadened beyond detection or shifted to regions where
157

158

their overlap with other more intense signals made their identification impossible.
This is consistent with the notion that the EI units are responsible for the
functionalization reactions with the nanofiber surface-bound carboxylic acids.52
The nanofiber content in the PPEI-EI-VGCFs was obtained through a
TGA experiment conducted with a heating rate of 10 oC in nitrogen. The
decomposition temperature of PPEI-EI was determined to be much lower than
that of the carbon nanofibers (Figure 5.3). Therefore, the PPEI-EI polymers in
PPEI-EI-VGCFs may be selectively removed in a relatively slow TGA scan,
leaving behind the thermally defunctionalized VGCFs at temperature of 700 oC.
According to the TGA traces, the carbon nanofiber contents in the PPEI-EIVGCFs prepared from acylation-amidation and direct heating are approximately
66% and 39%, respectively.
The two functionalization reactions were evaluated in terms of the amount
of VGCFs being functionalized and solubilized, with this determination being
based upon the mass balance for the nanofibers. The two functionalization
methods resulted in different amounts of soluble VGCFs (Table 5.1). For
example, appoximately 44% of VGCFs was soluble in solution for acylationamidation method, which is higher than that for the direct heating methods
(15.6%). The results for the functionalization of MWNTs with PPEI-EI via
acylation-amidation method was were also shown in Table 5.1, with 46%
functionalization yield based on the mass balance for MWNTs.
Nylon-MWNT and Nylon-VGCF. The functionalization of SWNT with
nylon was successfully developed through anionic ring-opening polymerization of
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Figure 5.3 TGA traces (heating rate 10 °C/min in continuous
nitrogen flow) of PPEI-EI-VGCFs from acylation-amidation (a),
PPEI-EI-VGCFs from direct heating (b), and PPEI-EI polymer
(c).
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carprolactam from nanotube surface.38 Here we applied the same grafting from
strategy to the functionalization of MWNTs and VGCFs with nylon-6, which
includes the covalent attachment of ε-caprolactam molecules-to-nanotubes, and
the anionic ring-opening polymerization of these bound ε-caprolactam species
with the same monomers in bulk (Scheme 5.1 and Scheme 5.2). Both nylonMWNT and nylon-VGCF samples were found to be soluble in several polar
solvents, such as formic acid and m-cresol, resulting in stable and dark-colored
homogeneous solutions. Figure 5.4 shows four vials containing equal volumes of
formic acid and nearly equal masses of purified VGCFs (Vial A), nylon-VGCFs
(Vial B), nylon-MWNTs (Vial C), and purified MWNTs (Vial D). These results
clearly indicate that both purified VGCF and MWNT were completely insoluble
in formic acid, while both nylon-MWNT and nylon-VGCF formed stable, darkcolored solution that exhibited no discernible particulate materials while also
remaining stable for a period of at least 4 weeks. Since nylon is colorless, the dark
solution color serves as a visual indicator for the presence of MWNTs and
VGCFs in solutions.
More direct evidence for the presence and the dispersion of MWNTs and
VGCFs in dark-colored solutions was demonstrated by STEM and AFM analyses.
For nylon-MWNT, the specimen for AFM analysis was prepared by spraying a
dilute formic acid solution of the sample onto a mica substrate. During the
spraying, the substrate was kept at 120 °C to facilitate rapid solvent evaporation
in an effort to preserve the original nanotube dispersion in the solution. Figure 5.5
shows a representative AFM topographic image from the analysis of such a
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specimen, with well-dispersed individual MWNTs. The STEM samples were
prepared by placing a few drops of nylon-VGCFs solution onto carbon-coated
copper grid, followed by evaporation of the solvent. As shown in Figure 5.6(a),
individual VGCFs rather than aggregates or bundles are obtained after
functionalization. At a high resolution (Figure 5.6(b)), the images show that
VGCFs surfaces are partially covered by amorphous materials, which are most
likely the attached nylon polymers.53
To evaluate the content of both the MWNTs and VGCFs, the nylon
functionalities on the surfaces of these nanostructures were thermally removed in
TGA. Figure 5.7 shows TGA traces of the nylon-functionalized MWNTs and
VGCFs in reference to commercially available nylon 6 (Acros, Mn ~ 10 000).
The experiments were carried out in nitrogen atmosphere with a heating rate of 10
°C/min. Because there is no meaningful weight loss for the purified pristine
MWNT and VGCF samples below ~600 °C, the weight loss, as a result of thermal
defunctionalization, can be used to estimate the MWNT and VGCF contents in
these functionalized samples. According to the residual sample weights at 600 °C,
the estimated MWNT and VGCF contents in the soluble fractions are 77%, 56%,
respectively. These are obviously rough estimates because of possible
contributions from the trapping of functional groups in the nanotube aggregates
after defunctionalization.
The solubility of nylon-functionalized MWNTs and VGCFs enabled highresolution NMR characterization in solution. The

13

C spectra of nylon-

functionalized MWNTs and VGCFs are compared with that of neat nylon-6
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(Acros, Mn ~ 10 000) in Figure 5.8. All spectra were acquired at the same
solution concentration of 3 mg/mL in regular formic acid by using deuterated
chloroform for locking at room temperature. The 13C spectra of nylon-attached to
MWNTs and VGCFs are mostly similar to that of free nylon, with the spectra of
the attached nylon being somewhat broader.
The nylon-MWNTs and nylon-VGCFs samples were characterized by
resonance Raman spectroscopy. Figure 5.9 shows the Raman spectrum of nylonMWNTs

compared

with

those

of

purified

MWNTs

and

thermally

defunctionalized nylon-MWNT samples. The Raman spectrum (785 nm
excitation) of nylon-MWNTs are subject to strong luminescence interference,
similar to those found in other functionalized carbon nanotubes.38 After the
thermal treatment of these samples at 600 oC in a nitrogen atmosphere to remove
the functional groups, the strong luminescence interference was completely
eliminated. From the comparison in Figure 5.9, the spectrum of the thermally
defunctionalized nylon-MWNT sample again exhibits the characteristic MWNT
peaks at 1310 cm-1 (D-band), 1580 cm-1 (tangential G-band), and 2660 cm-1 (D*band), which shows that no fundamental difference between the solubilized and
pristine MWNTs.
Resonance Raman spectroscopy was also used to characterize nylonVGCFs (Figure 5.10). Similar luminescence interference to that of functionalized
nylon-MWNT sample was observed with the D-band at 1310 cm-1, tangential Gband at 1580 cm-1 feature, which indicates that the VGCFs are well-dispersed in
the nylon-functionalized VGCF sample. As expected, a removal of the functional
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Figure 5.9 Raman spectra (785 nm excitation) of the nylon-MWNTs
sample before (top) and after (middle) TGA and purified MWNTs
(bottom).
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Figure 5.10 Raman spectra (785 nm excitation) of the nylon-VGCNFs
sample before (top) and after (middle) TGA and caprolactam-SWNT
(bottom).
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groups in the thermal defunctionalization of the funtionalized VGCF sample
eliminated the luminescence interference, with the Raman spectrum showing the
same characteristic features of purified VGCFs. However, compared with
MWNTs, there is no D*-band at 2660 cm-1 in the Raman spectrum of VGCFs.
The shared solubility and full compatibility of nylon-functionalized
MWNTs and VGCFs with nylon-6 polymer in formic acid allowed their intimate
mixing in solution and thereby enabled the fabrication of high quality
nanocomposite fibers. The electrospinning parameters used to produce the
composite fibers were chosen from a set of optimized parameters after a series of
systematic studies were carried out to determine the effects of flow rate, polymer
and carbon nanostructures concentration, the voltage applied and the tip-to-target
distances on the spinnability, jet stability, and morphology of the polymer fibers,
with and without MWNTs and VGCFs encapsulation. 10-12 wt % of the polymer
solution was found to be the appropriate concentration for a more stable polymer
jet. Because the as-prepared nylon-functionalized MWNTs and VGCFs solutions
exhibited low shear and elongational viscosity, the nanofibers could not be
formed by electrospinning. These solutions were then mixed with additional
commercial nylon in formic acid in order to increase the viscosity and thus
provide adequate spinnability for electrospinning. The mixture was electrospun
and directly deposited on the flat collector or around the rotating wheel to collect
a rope of oriented nanofibers with controlled diameter. Figure 5.11 shows an
example of scanning electron microscopy (SEM) images of nylon nanofibers
containing MWNTs. The fibers resembled typical electrospun nylon-6 fibers with
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an approximate diameter of 50-200 nm. The first attempt to image MWNTs
within the nanofibers proved to be very difficult due to the low contrast between
the polymeric matrix and the nanotubes and to the small diameter of the
nanotubes relative to the nanofibers. Since the diameter of the VGCFs is much
larger than nanotubes, in some cases it was possible in some cases to identify
VGCFs within some of the nanofibers. Consequently, TEM analysis was better
able to selectively distinguish and image both MWNTs and VGCFs within
nanofibers (Figure 5.12). Since the MWNTs and VGCFs possess a high electron
density compared with the nylon polymer matrix, they appear as darker tubular
structures embedded in the nylon polymer. As shown in Figure 5.12, it is clearly
evident that individual MWNTs and VGCFs were successfully embedded in the
dispersing polymer matrix. In many regions of the electrospun nanofibers the
embedded nanotubes appeared to be well-oriented along the fiber axis.
Another major goal of this work was to achieve macroscopic orientation
of MWNTs and VGCFs in the polymer matrix of nanofibers during
electrospinning. The high aspect ration of MWNTs and VGCFs makes them
highly anisotropic in nature and their orientation is considered to be of significant
importance towards the creation of many meaningful technological applications.
By aligning them in the polymer matrix, the strength, stiffness, electrical and
thermal properties of the composite can be controlled. We have developed an
effective method for electrospinning various polymers into well-aligned fibers by
combining electrospinning with a cylinder collector with high rotating speed and
additional mechanical stretching of the film. However, this very high speed
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(~1700 round per minute) electrospinning process only managed to improve the
alignment of the film to a certain extent. Therefore, to complete the alignment
process, thin film was made from the electrospun nanofibers and mechanically
stretched at 100 ̊C by applying a constant load. The same approach was applied in
the orientation of MWNTs and VGCFs in the polymer matrix of nanofibers. SEM
images in Figure 5.13 show that these polymeric carbon nanocomposites fibers
(200-400 nm) are well aligned in the direction of the stretch.

5.4 Discussion

There are many examples in the literature reporting the successful surface
functionalization of carbon nanotubes. For example, Haddon et al. have shown
that single-walled carbon nanotube bundles can be exfoliated with 2.6 M nitric
acid to create individual SWNTs bearing terminal carboxylic acid groups.54 Since
vapor grown carbon nanofibers have similar surface structure to that of carbon
nanotubes and possess edge-site carbon atoms of each graphene layer terminating
the nanofiber surface, they are especially suitable for surface functionalization.
Consequently, we used the same approach for the functionalization of MWNTs
with PPEI-EI to functionalize VGCFs with PPEI-EI.50 Mechanistically, the
functionalization of VGCFs with PPEI-EI probably occurs through the nanofiber
surface-bound carboxylic acid moieties, which are produced during the
production and the subsequent oxidative purification under strong acidic
conditions. Compared to the direct heating method, the acylation-amidation
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method was more efficient for the functionalization of VGCFs with PPEI-EI,
which might be a result of the higher reactivity of nanofiber-bound acyl chlorides
than nanofiber-bound acrylic acids. As illustrated in Figure 5.2, Figure 5.3, and
Table 5.1, VGCFs showed similar results with MWNTs. When acylationamidation method was used, the functionalization yields for both VGCFs and
MWNTs were around 40%.
Both MWNTs and VGCFs were functionalized and solubilized with nylon
6 via the anionic ring opening polymerization method developed in Chapter 4.38
Compared to the functionalization of MWNTs and VGCFs with PPEI-EI, the
anionic ring opening polymerization is more efficient. The functionalization of
MWNTs/VGCFs with PPEI-EI involved the bonding of PPEI-EI to the nanotubeand nanofiber-bound carboxylic acid groups and the attachment of a small
number of chains hindered diffusion of additional PPEI-EI macromolecules to the
surface, thereby leading to low grafting density; while the anionic ring opening
polymerization method involved the immobilization of small molecules of
caprolactam onto the nanotube/nanofiber surface followed by in situ surface
initiated

polymerization

to

generate

the

nylon

6-functionalized

nanotubes/nanofibers. Therefore, the functionalized carbon nanotubes/nanofibers
with high grafting density are easily synthesized through the anionic ring opening
poltmerization method.
The functionalization of VGCFs with nylon 6 described here is probably
initiated in a manner shown in Figure 5.14. The first step is the attachment of
caprolactam to the surface of carbon nanofibers through the amidation reaction
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(Figure 5.14(b)). The second step in the anionic polymerization is believed to be a
reaction of a caprolactam ring with the catalyst sodium to form a caprolactam
anion and hydrogen (Figure 5.14(a)). The third step involves the nucleophilic
attack of caprolactam anion on the endocyclic carbonyl group of caprolactanVGCFs, resulting in an ionic intermediate that may be stabilized by the
potentially overlapping orbitals in the resonance systems of the adjoining amide
groups (Figure 5.14(c)). The system can be protonated by reaction with
caprolactam monomer to continue the polymerization process (Figure 5.14 (d and
e)). Generally speaking, the release of ring strain is the driving force of the
polymerization.
According to this VGCF functionalization process, nylon 6 was covalently
attached to the surface of carbon nanotubes and carbon nanofibers, which was
confirmed by the

13

C spectra of nylon-MWNTs and nylon-VGCFs as shown in

Figure 5.8. The signal broadening for nylon-MWNTs and nylon-VGCFs may be
attributed to the attachment of nylon to carbon nanotubes and nanofibers as
species of high molecular weight and low mobility.51
The good dispersion of carbon nanotubes and nanofibers in the
functionalized samples was reflected by the strong luminescence interference in
resonance Raman measurements (Figure 5.9 and 5.10). This strong luminescence
background, as discussed in the literature,3 is an indication of the well dispersion
and functionalization of nanotubes with nylon. The luminescence may be
attributed to well-passivated nanotube and nanofiber surface defects which act as
traps for the photoexcitation energy. Upon stabilization by the functional groups,
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these surface defects may become strongly luminescent. After the functional
groups were removed by TGA, the strong luminescence was completely
eliminated. The elimination may due to the known inter-tube quenching effect
associated with the bundling of nanotubes and nanofibers.
As shown in Figure 5.9 and Figure 5.10, it was interesting to notice that
the D-band of VGCFs was broader than that of MWNTs while the width of Gbands were closely adjacent to one another. When compared with MWNTs, no
D*-band at 2660 cm-1 was detected in the Raman spectrum of VGCFs. According
to Lee et al.,55 the broadening of D-band and absence of D*-band may be
interpreted as an indication of interior structural quality of VGCF compared to
carbon nanotubes.
Electrospinning was used for the fabrication of polymer/carbon
nanocomposite nanofibers with an internal macroscopic orientation of carbon
nanotubes and nanofibers. TEM images (Figure 5.12) clearly show that the
individually embedded nanotubes and nanofibers appeared to be well-oriented
along the fiber axis. This exact orientation towards the axis is a result of the
original dispersion which mainly contained individual nanotubes rather than
aggregates or bundles. Before electrospinning, the MWNTs and VGCFs in the
solution were randomly oriented. However, due to the elongation of the fluid jet,
the nanotubes/nanofibers are now oriented along the streamlines of the
electrospinning solution during the electrospinning.45
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and carbon nanofibers with nylon 6.
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5.5 Summary

The methodologies developed for the functionalization and solubilization
of carbon nanotubes can be applied for the functionalization and solubilization of
vapor-grown carbon nanofibers. The resulting functionalized VGCFs are
dispersed well in solution and can be used for the fabrication of high-quality
polymer/carbon nanocomposites.
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